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Food intake is the product of meal size and frequency. Meal size is determined by sensory 
feedback signals that arise from the gastrointestinal (GI) tract and other digestive organs during 
feeding. Hindbrain glucagon-like peptide-1 (GLP-1) and prolactin-releasing peptide-positive 
noradrenergic A2 neurons (PrRP-positive) are anatomically poised to receive multimodal 
ingestive/metabolic-related information and engage local oral motor circuits that govern feeding. 
Moreover, multiple lines of evidence support a role for signaling from these populations in the 
suppression of food intake, while a role in the day-to-day control of meal size is less clear. 
Considering this, we hypothesized that GLP-1 and PrRP A2 neurons participate in satiation. 
 Results from studies conducted herein demonstrated that the proportion of GLP-1 and A2 
neurons that were activated by food intake closely reflects both the volume and caloric value of 
the food consumed, and this activation was modulated by experience with consuming unusually 
large meals. Among GLP-1 neurons, those in the caudal nucleus of the solitary tract (cNTS) 
were more sensitive than those in the neighboring medullary reticular formation (MRF), 
supporting direct vagal afferents as an important route by which sensory information recruits 
 
 v 
these neurons. PrRP-positive A2 neurons were more sensitive than PrRP-negative A2 neurons to 
feeding-related sensory signals, suggesting that PrRP may be a particularly important among the 
many neuropeptide products of A2 neurons in the context of feeding control. In Chapter 4, we 
demonstrated that blocking central GLP-1 receptors produced larger and longer meals consumed 
during the latter phases of the feeding period, without changing meal frequency or the interval 









PREFACE .................................................................................................................................... XI 
1.0 INTRODUCTION................................................................................................................ 1 
1.1 INHIBITION OF FOOD INTAKE: SATIATION VS. SATIETY ......................... 1 
1.2 BIOLOGICAL BASIS OF SATIATION: PIONEER STUDIES ............................ 4 
1.3 NEURONAL PHENOTYPES OF THE CAUDAL NUCLEUS OF THE 
SOLITARY TRACT (CNTS): GLP-1 AND PRRP SECOND SECTION ...................... 7 
1.4 ANATOMICAL DISTRIBUTION OF GLP-1 AND PRRP-POSITIVE 
NEURONS ............................................................................................................................. 7 
1.5 STIMULI THAT ACTIVATE GLP-1 AND PRRP NEURONS ........................... 13 
1.6 EFFERENT TARGETS OF GLP-1 AND PRRP NEURONS ............................... 15 
1.7 PHARMACOLOGICAL AND GENETIC MANIPULATION OF CENTRAL 
GLP-1 AND PRRP SIGNALING AND THEIR EFFECTS ON FOOD INTAKE ...... 16 
1.8 DO GLP-1 AND PRRP NEURONS PARTICIPATE IN SATIATION? ............. 20 
2.0 DIFFERENTIAL ACTIVATION OF GLP-1 AND PRRP-EXPRESSING NA 
NEURONS IN THE CAUDAL NUCLEUS OF THE SOLITARY TRACT IN NON-
LIST OF TABLES ...................................................................................................................... 
 vii 
ENTRAINED RATS AFTER INTAKE OF SATIATING VS. NON-SATIATING 
MEALS... ..................................................................................................................................... 23 
2.1 INTRODUCTION ..................................................................................................... 23 
2.2 MATERIAL AND METHODS ................................................................................ 26 
2.3 RESULTS ................................................................................................................... 32 
2.4 DISCUSSION ............................................................................................................. 44 
3.0 HINDBRAIN GLP-1 NEURONS TRACK INTAKE VOLUME AND PROMOTE 
SATIATION IN MEAL-ENTRAINED RATS ......................................................................... 49 
3.1 INTRODUCTION ..................................................................................................... 49 
3.2 MATERIAL AND METHODS ................................................................................ 52 
3.3 RESULTS ................................................................................................................... 59 
3.4 DISCUSSION ............................................................................................................. 76 
4.0 GENERAL DISCUSSION ................................................................................................ 83 
4.1 SUMMARY AND INTERPRETATION ................................................................. 83 
4.2 DIFFERENTIAL ACTIVATION: PRRP V. GLP-1 ............................................. 87 
4.3 SATIATION VS. STRESS-INDUCED HYPOPHAGIA: IMPORTANCE OF 
INCLUDING NON-MANIPULATED CONTROLS ...................................................... 92 
4.4 INTERPRETING DISCREPANCIES BETWEEN PUBLISHED EX9 STUDIES: 
CONSIDERING PRESENT RESULTS ........................................................................... 93 
5.0 FUTURE DIRECTIONS ................................................................................................... 95 
APPENDIX A: ACTIVATION OF PRRP-POSITIVE NEURONS IN CNTS IN MEAL 
 
ENTRAINED RATS ................................................................................................................... 97 
 viii 
APPENDIX B: SATIATION AND STRESS-INDUCED HYPOPHAGIA:  EXAMINING 
THE ROLE OF HINDBRAIN NEURONS EXPRESSING PROLACTIN-RELEASING 
PEPTIDE (PRRP) OR GLUCAGON-LIKE PEPTIDE 1 (GLP-1) ...................................... 102
BIBLIOGRAPHY .................................................................................................................... 136
   
ix 
LIST OF TABLES 
Table 1:  Meal-related statistics in non-entrained rats on the final test day ................................. 33 
Table 2. Meal-related statistics in meal-entrained rats on the final test day (Experiment 1) ....... 62 
Table 3. Meal pattern data in meal-entrained rats ......................................................................... 75 
 x 
LIST OF FIGURES 
 
Figure 1. Feeding-related feedback signals: satiation vs. satiety .................................................... 3 
Figure 2. Schematic depicting decerebration .................................................................................. 6 
Figure 3. Anatomy of GLP-1 and DBH-positive (including PrRP-positive) neurons within the 
cNTS ............................................................................................................................................. 11 
Figure 4. Examples of GLP-1+cFos and DBH+PrRP+cFos immunolabeling in cNTS ............... 36 
Figure 5. GLP-1 neuronal activation in meal-entrained rats ......................................................... 38 
Figure 6. A2 neuronal activation in non-entrained rats ................................................................ 40 
Figure 7. Meal size and activation of GLP-1-positive neurons in non-entrained rats .................. 42 
Figure 8. Meal size and activation of PrRP-positive neurons in non-entrained rats ..................... 43 
Figure 9. Average daily 1 h LD intake during the meal-entrainment acclimation period and on 
the final test day in Experiment 1. ................................................................................................ 61 
Figure 10. GLP-1 neuronal activation in meal-entrained rats ....................................................... 64 
Figure 11. Example of GLP-1 and cFos dual immunolabeling in cNTS ...................................... 65 
Figure 12. Relationship between amount consumed (as %BW) and cNTS GLP-1 neuronal 
activation in meal-entrained rats consuming different diets (Experiment 1). ............................... 68 
Figure 13. Daily food intake (expressed as kcal) during the meal-entrainment acclimation.......70
Figure 14. Cumulative 2h Ensure intake in ad-lib fed, meal-entrained rats................................. 72 
Figure 15. Differential activation of cNTS GLP-1 and PrRP-positive neurons ........................... 91 
Figure 16. Activation of PrRP-positive neurons in meal-entrained rats ....................................... 99 
Figure 17. Meal size and activation of PrRP-positive neurons in meal-entrained rats ............... 101 
Figure 18. Location of PrRP-positive and GLP-1-positive neurons in the rat hindbrain. .......... 112 
Figure 19. Summary schematic of our working hypothesis. ...................................................... 120 
 xi 
PREFACE 
Neither this dissertation nor my development as a young scientist would have been possible 
without the support of many people. Most of all, I would like to thank my mentor Linda 
Rinaman for continually challenging me to think, write, and conduct experiments like a top-
notch scientist. I would also like to extend the deepest heartfelt thank you to my former lab mate 
Dr. James Maniscalco for being the best graduate student role model and friend I could have 
asked for during my first 4 years. Thank you to Vicki Maldovan, Li Cai, and Huiyuan Zheng for 
their technical support throughout my graduate career and to my undergraduate mentees 
Elizabeth Davis and Mitchell Bayne for their technical contributions and enthusiasm. I would 
also like to thank Joan Blaney, Patti Argenzio and Marlene Nieri for being so reliable and 
supportive when it came to administrative manners. Thank you to my husband Evan for his 
continued support and acceptance despite not always understanding this whole graduate school 
thing. Lastly, thank you to my parents, Nancy and Fritz, for their undying interest in my graduate 
endeavors, their mentorship and for instilling in me an interest in scientific pursuit and 






LIST OF ABBREVIATIONS 
 
ANGII angiotensin II 
AP  area postrema 
ARC  arcuate nucleus of the hypothalamus 
BNST  bed nucleus of the stria terminalis 
BW  body weight 
CCK  cholecystokinin 
CNS  central nervous system 
cNTS  caudal nucleus of the solitary tract    
cVLM  caudal ventrolateral medulla 
DBH  dopamine-beta-hydroxylase 
diEN  diluted Ensure 
DMH  dorsomedial nucleus of the hypothalamus 
DMV  dorsal motor nucleus of the vagus 
DVC  dorsal vagal complex 
EN  Ensure 
Ex9  Exendin-3 (9-39) 
GI  gastrointestinal 
GLP-1  glucagon-like peptide-1 
GLP-1R glucagon-like peptide-1 receptor 
GPR10 G-protein coupled receptor 10 
h  hour(s); refers to a period of time 
 xiii 
hr  hour; refers to a time of day 
i.c.v.  introcerebroventricular 
IMI  intermeal interval 
LD  liquid diet 
LiCl  lithium chloride 
MRF  medullary reticular formation 
NA  noradrenaline/noradrenergic 
NAcc  nucleus accumbens 
NF  non-fed 
PB  phosphate buffer 
PF  paraformaldehyde 
PrRP  prolactin-releasing peptide 
PVN  paraventricular nucleus of the hypothalamus 
RES-LD restricted liquid diet 
SAL  saline 
SON  supraoptic nucleus 
TH  tyrosine hydroxylase 
VTA  ventral tegmental area 
   
 1 
1.0  INTRODUCTION 
1.1 INHIBITION OF FOOD INTAKE: SATIATION VS. SATIETY 
Although energy needs are continuous, energy intake in omnivores is intermittent. In situations 
where food is freely available, ingestive events occur in discrete bouts referred to as meals. 
Therefore, cumulative food intake in a given period of time is equivalent to the product of meal 
number and meal size. Changes in food intake must be the result of stimulatory or inhibitory 
factors producing changes in meal size and/or changes in the interval between them (meal 
frequency) (Davis, 1989). While copious studies have been dedicated to understanding the 
mechanisms and signals that stimulate food intake (e.g., hunger, reward value, circadian 
rhythms), the widespread existence of states of chronic nutritional excess (i.e., obesity) 
underscores the importance of understanding signals that inhibit feeding. The research herein is 
one such example. 
In most human societies, the pattern of ingestive bouts in a given individual is heavily 
influenced by environmental (e.g., culture, social) and idiosyncratic (habits, lifestyle, health-
related, and genetic) factors. While understanding ingestive behavior in complex human 
societies is important, animal studies offer an ideal avenue to study the fundamental behaviors 
and biological mechanisms governing feeding behavior. It is from animal studies that the field 
of ingestive behavior derived its widely accepted terms "satiation" and "satiety" that refer to 
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the inhibition of meal size and meal frequency, respectively (Blundell and Bellisle, 2013). 
More specifically, satiation refers to the accumulation of inhibitory signals within a single meal 
(ultimately terminating it). Satiety refers to the point at which a meal ends and the continued 
inhibition of eating that occurs until the initiation of the subsequent meal (defining the duration 
of the inter-meal interval).  
Satiation and satiety are not independent processes. Both are influenced by a common 
set of internal (e.g., sensory, cognitive, metabolic) and environmental (e.g., social, cultural) 
stimuli and they directly affect each other (e.g., the size of a meal certainly influences the 
amount of time until the next one). However, in the most basic sense, satiation and satiety are 
successive processes governed by largely non-overlapping biological mechanisms (Figure l). 
Satiation is a sensory-driven process that involves the integration of mechanical, chemical, and 
hormonal signals that are generated when ingesta contacts the GI tract. On the other hand, 
satiety involves the integration of intestinally-derived signals with information about adiposity, 
energy expenditure, metabolic status, circadian rhythms, etc, that begins at the point of meal 
termination (Davis, 1989; Smith, 1996; Blundell and Bellisle, 2013). Therefore, keeping this 
distinction in mind offers a useful approach for studying the effect of experimental 
manipulations on feeding behavior and for better understanding the basic neural mechanisms 


















Figure 1. Feeding-related feedback signals: satiation vs. satiety 
A series of multimodal negative feedback signals promote the inhibition of food intake during 
and after a meal. The successive and distinct nature of these signals supports the 






1.2 BIOLOGICAL BASIS OF SATIATION: PIONEER STUDIES 
Meal number is regulated by forebrain and hypothalamic circuits that encode information about 
environmental events and context, learned associations, reward value, and energy status between 
meals. Conversely, meal size regulation is a sensory-driven process that arises from direct 
contact between ingested food and sensory receptors along the GI tract (Smith, 1996; Smith, 
1998; Woods and Ramsay, 2000; Morton et al., 2006). Early landmark studies in rats undergoing 
sham-feeding were influential in revealing the peripheral origin of these feeding-generated 
sensory signals and their specific effects on feeding behavior.   
During sham-feeding procedures, a surgically placed gastric cannula actively removes 
ingested food as it enters the stomach, allowing experimenters to dissociate the contributions of 
orosensory/pregastric (those arising from the mouth, tongue, throat, esophagus, etc.) versus 
gastric/postgastric (those arising from the stomach and intestines) sensory signals on feeding 
behavior. These studies consistently demonstrated that rats undergoing their first experience with 
sham-feeding displayed similar intake and licking behavior during the initial minutes of sham-
fed meals as did rats feeding normally. However, these sham-fed meals were substantially larger 
than regular meals (Davis and Campbell, 1973; Young et al., 1974; Kraly et al., 1978). Together 
these observations indicated that post-gastric nutrient contact provides an important unlearned 
inhibitory signal that determines meal size, while orosensory (pre-gastric) signals are sufficient 
to initiate and maintain feeding.  
Similar localization studies have been applied to the central nervous in order to better 
understand the neurological mechanisms that promote satiation. Pioneer work in the chronic 
decerebrate (CD) rat performed in the 1970-1990s implicated the hindbrain as home to the 
central networks that govern satiation (Grill and Norgren, 1978a; Seeley et al., 1994; Smith, 
 5 
2000). Decerebration refers to the complete surgical isolation of the hindbrain from the forebrain 
via a knife cut through the rostral brainstem (just rostral to the cerebellum), abolishing the 
reciprocal communication between forebrain and hindbrain structures (Figure 2).  
Despite possessing the locomotor capabilities and oral motor control involved in 
procuring and consuming food, CD rats do not begin eating unless food is placed directly in their 
mouths, indicating that the brainstem alone is insufficient for meal initiation. However, CD rats 
do clearly stop eating (consume distinct meals) (Grill and Norgren, 1978a; Seeley et al., 1994; 
Smith, 2000) and adjust the size of those meals based on palatability of the food (Grill and 
Norgren, 1978b; Grill and Kaplan, 1992). Together, these observations indicate that the 
brainstem only responds to sensory signals that arise upon nutrient contact with the GI tract (i.e., 
is not sufficient to support the motivational drive to procure food). However, the brainstem is 
sufficient to integrate positive and negative feedback signals upon feeding commencement and 
inhibit the motor patterns that drive feeding. Conversely, the CD rat is unable to perform more 
complex controls of eating such as adjusting feeding behavior based on learned associations, 
food availability, or metabolic status, (Grill and Norgren, 1978a; Seeley et al., 1994; Grill and 
Kaplan, 2002) indicating that descending input from the forebrain is required for these 
adjustments. Together, studies in CD rats provided critical evidence that the hindbrain is 
sufficient to respond to the sensory signals generated during feeding (and thus perform satiation) 
but requires descending input from other brain structures when adjusting food intake to internal 
or external stimuli [reviewed in (Seeley et al., 1994; Smith, 2000, Woods 1990; Grill and 










Figure 2. Schematic depicting decerebration  
Space between the rat forebrain (left) and hindbrain (right) emphasizes the dissociation between 
the structures produced by decerebration. Behavioral studies in decerebrate rats revealed that the 
hindbrain contains all of the necessary neural equipment to integrate feeding-generated sensory 
signals and subsequently terminate a meal. Figure from (Smith, 2000).  
  
 7 
1.3 NEURONAL PHENOTYPES OF THE CAUDAL NUCLEUS OF THE SOLITARY 
TRACT (CNTS): GLP-1 AND PRRP SECOND SECTION 
Pioneer studies implicated the brainstem as a critical structure in the regulation of meal size. 
However, the neuronal phenotypes that participate in hindbrain and forebrain circuits that control 
feeding behavior (including satiation) are just beginning to be unraveled. Within the caudal 
brainstem, neurons that reside in the cNTS are the first to receive and process ingestion-related 
visceral sensory signals (Shapiro and Miselis, 1985; Altschuler et al., 1989b; Rinaman et al., 
1989; Appleyard et al., 2007; Grill and Hayes, 2009, 2012). Although the cNTS is 
neurochemically diverse, the present work focuses on two neuronal populations that we propose 
play a role in satiation: one that synthesizes glucagon-like peptide-1 (GLP-1) and another 
comprises a subset of noradrenergic (NA) A2 neurons that also express prolactin-releasing 
peptide (PrRP). A2 (including PrRP) and GLP-1 cell groups give rise to the most widely-
distributed projections to medullary, mesencephalic, diencephalic, and limbic regions of all 
cNTS neuronal cell groups considered thus far [reviewed in (Rinaman, 2010, 2011; Grill and 
Hayes, 2012), see also Section 2.3]. Therefore, A2 and GLP-1 neurons represent a route through 
which interoceptive feedback from the body can influence feeding behavior.  A role for these 
neuronal populations in physiological food intake is unclear.   
1.4 ANATOMICAL DISTRIBUTION OF GLP-1 AND PRRP-POSITIVE NEURONS 
Prolactin-releasing peptide was identified as an endogenous ligand for the human orphan G-
protein-coupled receptor hGR3/GPR10 (from here on referred to as GPR10), and earned its name 
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because it induces prolactin secretion from anterior pituitary cells in vitro (Hinuma et al., 1998). 
However, PrRP is absent from the external layer of the median eminence (Maruyama et al., 
1999; Morales et al., 2000), and there is no evidence that endogenous PrRP plays any 
physiological role in prolactin release. Instead, PrRP is produced by a (large) subset of A2 
neurons in the cNTS and has demonstrated roles in stress and energy regulation (see Section 
2.4).  
 Neurons that express GLP-1 and PrRP are phenotypically distinct, but co-distributed 
within the cNTS extending from the upper cervical spinal cord through the caudal area postrema 
(AP, Figure 3A). A2 neurons can be visualized using immunohistochemical labeling of 
dopamine-beta hydroxylase (DBH), the rate-limiting enzyme of norepinephrine synthesis. 
Therefore, the PrRP-positive subset of A2 neurons can be visualized using co-
immunolocalization of DBH and PrRP (Chapter 3, Appendix A). Within the cNTS, PrRP-
positive neurons cluster in medial and commissural subnuclei of the cNTS, whereas GLP-1 
neurons are primarily localized in the lateral subnucleus (Figure 3 B,C). Besides those in the 
cNTS, PrRP-positive neurons comprise a subset of the A1 NA cell group within the caudal 
ventrolateral medulla (cVLM), and a small group of PrRP-positive neurons are present in the 
dorsomedial hypothalamus (DMH) (Chen et al., 1999; Iijima et al., 1999; Maruyama et al., 
1999). GLP-1 neurons are also scattered in regions somewhat dorsal and medial to the A1 cell 
group in the medullary reticular formation (MRF) (Larsen et al., 1997; Vrang et al., 2007; Vrang 
and Grove, 2011).  
 Many reports cited in the present Introduction leave open the possibility that functions 
ascribed to central signaling by PrRP-positive and/or GLP-1 neurons include signaling from 
neurons located not within the cNTS, but within the MRF/cVLM and/or the PrRP-expressing 
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neurons in the DMH. However, limited evidence suggests that GLP-1 and PrRP neurons within 
the cNTS vs. those in other brainstem/hypothalamic regions project to different brain areas or 
maintain separate functions, although this possibility should be examined. For example, NA and 
GLP-1 neurons within the cNTS receive direct visceral sensory input (Appleyard et al., 2007; 
Hisadome et al., 2011), whereas those in the MRF do not. In the absence of specific evidence to 
discriminate between PrRP or GLP-1 neurons within the cNTS vs. those in adjacent brainstem 
regions, a conservative approach dictates that projections and functions ascribed to chemically 
distinct neurons in either region should be considered likely to be shared by neurons in the other 
region. It also remains unclear whether subsets of cNTS PrRP and GLP-1 neurons project to 
different targets or the degree to which PrRP and GLP-1 neurons collateralize.    
 The cNTS is the "visceral" NTS, which is distinct from the more rostral "gustatory" NTS 
(Figure 3A). The cNTS is a component of the dorsal vagal complex (DVC), which also includes 
the AP and dorsal motor nucleus of the vagus (DMV, Figure 3B). The DVC is critical for 
autonomic and endocrine functions, because it relays visceral, hormonal, and somatic 
information from the body to the brain, thereby regulating stress responses, and energy balance. 
The AP is a circumventricular organ that is permeable to a wide variety of circulating factors. It 
contains intrinsic neurons as well as afferent projections to the cNTS that serve to translate 
chemical and hormonal signals from the periphery into neural signals. Sensory input from the 
respiratory, cardiovascular and gastrointestinal viscera also arrive via glutamatergic vagal 
sensory afferents. These vagal afferents synapse on cNTS GLP-1 and NA neurons (presumably 
at least some of which also express PrRP (Bailey et al., 2006; Appleyard et al., 2007; Hisadome 
et al., 2010, 2011). The cNTS also receives relayed synaptic input from the viscera via other 
brainstem nuclei (trigeminal, reticular) (Menétrey, 1987; Altschuler et al., 1989b; Menétrey, 
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1990) although whether these inputs are onto GLP-1 and PrRP neurons specifically is unknown. 
Due to the proximity and intercommunication with the AP in addition to direct vagal afferent 
innervation, GLP-1 and PrRP neurons are well poised to integrate multimodal information 












   
 
 
Figure 3. Anatomy of GLP-1 and DBH-positive (including PrRP-positive) neurons within 
the cNTS 
A) Schematic depicting a dorsal view of the NTS with the approximate boundaries of the caudal 
(“visceral”) and rostral (“gustatory”) components delineated by dotted lines. Dots indicate 
approximate distribution of GLP-1, PrRP-positive and PrRP- negative A2 neurons. C) GLP-1-
positive (green) and DBH (including PrRP)-positive neurons co-mingle within the cNTS (region 
indicated by black arrow in panel B) Schematics in A and B adapted from (Vrang and Larsen, 
2010) and level 70 of (Swanson, 2004), respectively. 4V= 4th ventricle, AP = area postrema, 
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NTSm = medial subnucleus of NTS, NTSl = lateral subnucleus of NTS, co = commissural 
subnucleus of NTS, DMX = dorsal motor nucleus of vagus; c = central canal, ts = solitary tract.  
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1.5 STIMULI THAT ACTIVATE GLP-1 AND PRRP NEURONS  
Numerous studies have shown that GLP-1 and A2/PrRP neurons are activated by of 
experimental treatments that activate GI vagal sensory afferents and/or reduce food intake 
including high doses of cholecystokinin octapeptide (CCK) (Rinaman, 1999a; Maniscalco and 
Rinaman, 2013), LiCl (Rinaman, 1999a; Lawrence et al., 2002), endotoxin (Rinaman, 1999a; 
Mera et al., 2006), hemorrhage (Morales and Sawchenko, 2003), and, of particular relevance to 
experiments conducted in Chapter 4, a ventricular injection of saline vehicle [(Maniscalco, in 
press) see also Section 5.4]. In these cited studies and many others, including studies conducted 
in Chapters 3-4, stimulus-induced “activation” of NA, PrRP, and/or GLP-1 neurons is generally 
characterized by double immunolabeling to localize nuclear cFos, the protein product of the 
immediate-early response gene, cfos, together with cytoplasmic proteins identifying the chemical 
phenotype of activated neurons. The studies conducted in this thesis used a binary index of cFos 
labeling, i.e., present as determined by visible nuclear immunolabeling in a given neuron, or 
absent when no nuclear immunolabeling was evident. No electronic tools were used to quantify 
the presence or intensity of cFos immunolabeling, although quantification was standardized by 
having the same researcher perform all cFos analyses.  
 It is important to consider that the threshold of input required to activate cFos expression 
may vary between neurons. Therefore, as a binary index of neural activation, the visible presence 
or absence of cFos immunolabeling in a given neuron poorly reflects the absolute magnitude of 
synaptic inputs, and provides no information regarding an individual neuron’s spike frequency. 
In order to better understand the firing properties of GLP-1 and PrRP neurons relative to a 
stimulus, more detailed electrophysiological experiments are required. However, quantitative and 
regional analyses of neural cFos expression permit assessment of stimulus induced activation 
 14 
across multiple populations of phenotypically identified neurons under control and experimental 
conditions, making it an ideal approach for testing hypotheses regarding neural sensitivity and/or 
function in vivo.  
 As demonstrated above, the collective results of studies utilizing cFos indicate that GLP-
1 and PrRP-positive neurons are consistently activated by stimuli that reduce food intake. While 
these studies provide convincing evidence that GLP-1 and PrRP-positive neurons are sensitive to 
the sensory signals that accompany experimentally-administered visceral stressors (and may 
contribute the reduction in food intake that accompanies them) (Thiele et al., 1998; Rinaman, 
1999b; Kinzig et al., 2002; Rinaman, 2003; Grill et al., 2004; Maniscalco et al., 2012b)), they do 
not provide insight into the sensitivities of these neurons to the visceral sensory signals generated 
during normal food intake. A limited number of studies have reported higher proportions of 
activation among phenotypically-identified  GLP-1 or DBH (including PrRP)-positive neurons in 
rats that have consumed a meal compared to compared to rats that did not eat (Rinaman et al., 
1998; Takayanagi et al., 2008; Gaykema et al., 2009). However, only one of these studies 
(Rinaman et al., 1998) has examined the potential relationship between activation of DBH-
positive neurons and the amount of food consumed, and that study did not examine the PrRP-
positive subset specifically. The relationship between amount consumed and neuronal sensitivity 
is particularly important given the proposed role for GLP-1 and DBH (including PrRP)-positive 
neurons in transducing feeding-related sensory signals to the brain during satiation, which 
consists of an on-going accumulation of inhibitory sensory signals (Section 1.1).  
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1.6 EFFERENT TARGETS OF GLP-1 AND PRRP NEURONS 
Prolactin-releasing peptide- and GLP-1-positive neurons are well positioned to participate in 
vago-vagal reflexes that modulate gastrointestinal motility, pancreatic hormone release, and 
other digestive-related autonomic processes associated with ingestion. Indeed, anatomical studies 
have shown that A2 (Hermann et al., 2005; Travagli et al., 2006; Pearson et al., 2007), including 
PrRP (Iijima et al., 1999) and GLP-1-positive (Llewellyn-Smith et al., 2011; Llewellyn-Smith et 
al., 2013) neurons project locally within the DVC, MRF, and spinal cord, regions that contain 
pre-autonomic neurons implicated in the control of autonomic function related to digestion. 
Functional studies have supported a role for PrRP (Grabauskas et al., 2004) and GLP-1 (Gulpinar 
et al., 2000) signaling within the brainstem in the regulation of gastric and intestinal motility. 
PrRP (Iijima et al., 1999) and GLP-1 positive (Larsen et al., 1997; Rinaman, 2010) axon 
varicosities are also present in spinal cord, pontine and medullary reticular nuclei that contain the 
pattern generators, pre-motor and motor neurons that control the somatic motor function 
associated with feeding (e.g., licking, chewing, swallowing, (Travers and Rinaman, 2002). 
Phenotypically-unidentified neurons within the PrRP/GLP-1-rich regions of cNTS and MRF 
have been shown to be synaptically linked to motor neurons that control feeding-relevant oral 
movements (Travers et al., 1997; Travers et al., 2010). It is unknown whether this group of 
neurons includes PrRP and/or GLP-1-positive neurons. It is also unknown whether or not PrRP 
and GLP-1 neurons (directly) communicate with each other. Nonetheless, PrRP and GLP-1-
positive neurons are ideally positioned to participate in the ingestive motor circuits that shape 
satiation.  
 Dual-labeling retrograde tracing and fiber lesion studies indicate that A2 (including 
PrRP-positive) and GLP-1 neurons also project to multiple higher brain regions implicated in 
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behavioral and physiological components of food intake (Rinaman, 1999a; Morales et al., 2000; 
Sarkar et al., 2003; Renner et al., 2010; Rinaman, 2010, 2011; Renner et al., 2012). 
Immunohistochemical and in situ hybridization analyses reveal particularly dense GLP-1 and 
PrRP terminal fields and/or receptor mRNA expression in the paraventricular hypothalamus 
(PVN), DMH, arcuate hypothalamus (ARC), supraoptic nucleus (SON), dorsomedial thalamus, 
and bed nucleus of the stria terminalis (BNST) (Dodd and Luckman, 2013) (Shughrue, 1996; 
Merchenthaler et al., 1999; Rinaman, 2010). However, results from studies using CD rats 
(Section 1.2) suggest that these PrRP/GLP-1 fibers are not necessary for meal termination. This 
does not preclude an important role for such projections in the modulation of basic sensory 
integration and motor output that comprise satiation (Figure 19).   
 
1.7 PHARMACOLOGICAL AND GENETIC MANIPULATION OF CENTRAL GLP-
1 AND PRRP SIGNALING AND THEIR EFFECTS ON FOOD INTAKE 
Due to its very short half-life (~ 2 minutes), peripherally-released GLP-1 is unlikely to bind to 
central GLP-1 receptors. Furthermore, PrRP is produced in relatively small amounts in the 
periphery (mostly in the intestines and adrenal gland) compared to in the caudal brainstem (Fujii 
et al., 1999). Therefore, the effects of receptor manipulation described in this section are most 
likely attributable to blocking GLP-1 and PrRP signaling of brainstem (and/or hypothalamic for 
PrRP) origin. However, the absence of a GLP-1 radio ligand has prohibited formal analyses of 
peripherally administered GLP-1 binding efficiency in the CNS. The ability of peripherally-
released PrRP to impact CNS receptor function has not been investigated.  
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Studies using pharmacological stimulation of GLP-1 receptor and GPR10 consistently 
report reductions in food intake in rats and mice (Tang-Christensen et al., 1996; Turton et al., 
1996; McMahon and Wellman, 1997; Asarian et al., 1998; McMahon and Wellman, 1998; 
Lawrence et al., 2002; Schick et al., 2003a; Abbott et al., 2005; Hayes et al., 2008; Williams et 
al., 2009; Onaka et al., 2010; Hayes et al., 2011a; Williams et al., 2011; Dickson et al., 2012; 
Kanoski et al., 2012). While important in revealing a potential role for these receptors in feeding, 
results of studies using this approach are not good indicators of a physiological role for these 
neuropeptide systems in food intake. To better understand the role of endogenous GLP-1 
signaling in satiation and long-term energy balance, one research group used a knockdown 
strategy in which short hairpin RNA was microinjected into the cNTS of adult rats to suppress 
endogenous GLP-1 expression; this produced a significant and long-lasting increase in daily food 
intake and body weight compared to control rats (Barrera et al., 2011). However, it might be 
argued that the brainstem surgery itself in that study had a marked and long-lasting effect to 
reduce food intake and body weight gain, and that knockdown of GLP-1 expression merely 
attenuated the deleterious effects of surgery (see Section 5.3 and Appendix B regarding satiation 
vs. stress-induced hypophagia). Evidence challenging a physiological role for GLP-1 signaling in 
daily food intake control comes from one study using GLP-1R−/− mice, which are lean and 
consume a similar number of daily calories compared to wild-type mice. However, GLP- 1R−/− 
mice display an apparent disturbance in satiation, such that termination of food intake is delayed 
early in the dark period, thereby prolonging the initial nocturnal meal. This is followed by a later 
suppression of intake to achieve caloric compensation (see Figure 5A in Scrocchi et al., 2000).  
 GPR10-deficient mice display late onset hyperphagia and obesity under ad lib feeding 
conditions (Gu et al., 2004; Mochiduki et al., 2010), but not in a one-time 16 h fasting/re-
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feeding protocol (Gu et al., 2004). In addition, GPR10 is required for the ability of exogenously 
administered PrRP and CCK to inhibit food intake in mice (Bechtold and Luckman, 2006). In 
another study, PrRP-deficient mice displayed increased meal size (but not frequency) under ad 
lib feeding conditions, increased intake after deprivation, and reduced responsiveness to the 
feeding-suppressive effects of exogenous CCK and leptin (Takayanagi et al., 2008), which 
endogenously function as satiety signals.  
 Genetic knockouts provide valuable information for a role of endogenous GLP-1/PrRP 
signaling in long term energy balance. However, because satiation and long-term changes in 
energy metabolism are modulated by similar factors (see Section 1.1), it can be difficult to 
separate a contribution of the manipulated signaling system to long-term energy balance vs. 
satiation in experiments using genetic knockouts.  Furthermore, such models are susceptible to 
developmental and compensatory effects that can make results difficult to interpret. Lastly, 
these approaches have not yet been applied to rats. 
 Pharmacological administration of GLP-1 receptor antagonist Exendin-3 (9-39) (Ex9) 
offers a simpler mechanism by which endogenous signaling can be acutely suppressed. 
Parenchymal administration of Ex-9 into subregions of the mesolimbic reward system, i.e., the 
ventral tegmental area (VTA) or nucleus accumbens (NAcc), increases short-term intake of 
chow, palatable high-fat diet, and sucrose in ad lib- fed rats (Dossat et al., 2011; Alhadeff et al., 
2012; Dickson et al., 2012; Dossat et al., 2013), suggesting that GLP-1 signaling in these regions 
may normally act to suppress reward-driven intake. Ex-9 targeted to the lateral hypothalamus 
enhances short term food intake in ad lib-fed rats (Schick et al., 2003a). Conversely, Ex-9 
injections targeted to the fourth ventricle or cNTS increase the amount of food consumed by rats 
after gastric distension, but not after intestinal nutrient infusions (Hayes et al., 2009). Results 
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from these studies support the view that endogenous GLP-1 signaling suppresses or limits food 
intake across a variety of experimental conditions, and the cNTS/hindbrain may be an especially 
sensitive site of action for this effect (Grill and Hayes, 2012). Interestingly, several studies have 
reported that central Ex9 administration fails to further increase food intake in food-deprived rats 
(Turton et al., 1996; Schick et al., 2003a; Williams et al., 2009). Upon considering novel results 
of studies conducted in this thesis, I speculate as to the reason for this discrepancy in the General 
Discussion (Section 5.4). Of the studies that have reported increased cumulative intake after 
central Ex9 administration, only one has provided convincing evidence that such treatment 
affects meal size, specifically (Dossat 2013). However, this study did not report whether the 
Ex9-induced increase in meal size resulted in increased cumulative intake. There is currently no 
pharmacological tool with which to antagonize GPR10. Therefore, the effects of acute disruption 
of endogenous PrRP signaling have been poorly investigated.  
 A potential interpretational problem in the studies cited above is the typical comparison 
of data from surgically manipulated and/or drug-infused rats with data from control rats 
subjected to sham surgery and/or infused with vehicle. While these are appropriate experimental 
controls, they are incomplete. The manipulations employed in these studies are often complex, 
requiring one or more surgical sessions (e.g., to equip animals with chronic brain cannulas or 
intravenous catheters), and acute handling for central or systemic drug injection. Such 
manipulations are themselves likely to promote some degree of stress-induced hypophagia, such 
that “baseline” food intake measured in animals after central or systemic vehicle treatment may 
be less than intake that would be observed under non-manipulated conditions. Accordingly, 
recent studies in our lab have shown that the mild stress associated with injection procedures 
activates GLP-1 neurons above the level of injected controls (Maniscalco, in press). Therefore, 
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the ability of centrally administered Ex-9 or anti-PrRP antibody to increase food intake relative 
to vehicle-injected controls could be interpreted as evidence that central GLP-1 or PrRP 
signaling promotes stress-induced hypophagia (Appendix A) rather than normal food intake.  
GLP-1 and PrRP-positive neurons are sensitive to variety of stimuli and blocking their 
receptor activity attenuates hypophagic responses to a variety of stressors (Appendix B). 
Therefore, it is particularly important to include non-manipulated controls in order to distinguish 
a contribution of GLP-1/PrRP signaling to normo-physiological food intake vs. a role in counter-
acting the hypophagic effects of experimental treatments. Furthermore, more work is necessary 
to better understand whether endogenous central GLP-1/PrRP signaling plays a role in meal size, 
meal number, or both.  
1.8 DO GLP-1 AND PRRP NEURONS PARTICIPATE IN SATIATION? 
Satiation is a brainstem-mediated process comprised of the integration of feeding-generated 
sensory cues from the GI tract with input regarding environmental, metabolic, cognitive, and 
conditioned information from the forebrain and digestive organs. A growing body of literature 
demonstrates that GLP-1 and PrRP-positive A2 neurons that reside in the cNTS are sensitive to 
multi-modal visceral sensory signals and may participate in central networks that control food 
intake. However, such studies have not provided convincing evidence for a role for GLP-1 and 
PrRP signaling in day-to-day feeding, nor if that role is to limit meal size and/or frequency.  
Therefore, we propose that GLP-1 and PrRP neurons are sensitive to the visceral sensory 
signals generated during feeding and thus are a route through which information about feeding 
status is conveyed to the CNS. Furthermore, we hypothesize that GLP-1 signaling subsequently 
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contributes to the termination of a meal.  My dissertation work, comprising the studies that 
follow, tested two critical components of this central hypothesis.  
In Chapter 3, I hypothesized that GLP-1 in cNTS and A2 (including PrRP-positive) 
neurons would be activated in rats undergoing their first experience with a 24h fast followed by 
access to a palatable liquid meal. Indeed, results indicated that both populations of neurons were 
sensitive to food intake and such activation was tightly correlated with the volume consumed. 
However, the relationship between neuronal activation and volume consumed was different for 
PrRP-positive A2, PrRP-negative A2, and GLP-1 neurons, suggesting differential sensitivities to 
feeding-generated signals across these three populations. However, in rats that consumed the 
largest meals (5 %BW), only 45% of PrRP neurons and 30% of GLP-1 neurons were activated.  
Therefore, in Chapter 4, we trained rats to consume even larger (> 5 %BW) meals in 
order to challenge the hypothesis that such meals would further activate GLP-1 and PrRP 
neurons. Furthermore, we used pharmacological blockade of GLP-1 receptors in ad lib-fed rats 
to challenge a causal role for GLP-1 signaling in satiation under these feeding conditions. In that 
study, data from non-injected rats was compared to data in rats injected with Ex9 and vehicle in 
order to reveal a role for endogenous GLP-1 signaling in satiation rather than in attenuating 
decreases in food intake associated with vehicle injection. Results obtained in Chapter 4 were 
consistent with our hypothesis: larger meals (12-13 %BW) produced more robust activation (up 
to 90%) of GLP-1 and PrRP neurons. Blocking GLP-1 signaling increased food intake compared 
to baseline intake, which was driven by a preferential increase in meal size.  
Together, results from my dissertation work demonstrate than GLP-1 and PrRP neurons 
effectively track the amount consumed. Also, in addition to reversing the hypophagia associated 
with vehicle injection, GLP-1 signaling contributes to satiation, and not satiety, by increasing 
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meal size and duration. However the effect to increase meal size occurred only once a substantial 
amount of food had already been consumed, supporting a role for endogenous GLP-1 signaling 
in promoting satiation selectively when food intake becomes exceptionally large. It remains 
unclear, however, which GLP-1 receptor populations are mediating such effects and 
whether/how endogenous PrRP signaling also contributes to satiation (see Section 6.0).  
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2.0  DIFFERENTIAL ACTIVATION OF GLP-1 AND PRRP-EXPRESSING NA 
NEURONS IN THE CAUDAL NUCLEUS OF THE SOLITARY TRACT IN NON-
ENTRAINED RATS AFTER INTAKE OF SATIATING VS. NON-SATIATING MEALS 
2.1 INTRODUCTION 
Food intake is the product of meal size and meal number (Smith, 1996). Meal number is 
regulated by cortical, limbic, striatal, and hypothalamic forebrain circuits, and is modulated by 
signals that convey information about environmental events, learned associations, reward, and 
energy status between meals [see (Woods and Seeley, 2000; Morton et al., 2006) and Section 1.1 
for reviews]. Conversely, meal size is controlled primarily at the level of the caudal brainstem 
(Smith, 1996), and is modulated by satiety signals arising from the GI tract and related digestive 
organs during the ingestion and digestion of food; these signals are conveyed largely by vagal 
sensory inputs to the NTS (Grill and Norgren, 1978a; Grill and Smith, 1988; Appleyard et al., 
2007; Hayes et al., 2009; Grill, 2010; Hisadome et al., 2011; Grill and Hayes, 2012). The NTS 
relays feeding-related visceral sensory signals to the forebrain, as well as to brainstem pattern 
generators and pre-motor neurons that control the motoric components of feeding (i.e., licking, 
chewing, and swallowing (Smith, 2000; Travers and Rinaman, 2002). Thus, NTS neurons are 
critically involved in receiving and processing GI satiety signals that terminate ingestive 
consummatory behaviors, thereby limiting meal size (Rinaman, 2010).  
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NTS neurons that receive and process satiety signals are neurochemically diverse 
(Rinaman, 2010). However, recent studies have implicated two intermingled but phenotypically 
distinct caudal NTS neuronal populations in meal size control: noradrenergic (NA) neurons that 
comprise the A2 cell group, and neurons that are immunopositive for glucagon-like peptide-1 
(GLP-1) (Rinaman, 2010; Vrang and Larsen, 2010; Rinaman, 2011). Based on increased 
expression of the immediate-early gene product cFos, results in laboratory rats indicate that A2 
and GLP-1 neurons are stimulated by experimental treatments that activate GI vagal sensory 
afferents with synaptic inputs to the caudal NTS (Rinaman et al., 1998; Rinaman, 1999a; Vrang 
et al., 2003; Gaykema et al., 2009; Maniscalco and Rinaman, 2013).  Such treatments include 
mechanical gastric distension (Vrang et al., 2003) and systemic administration of CCK (Rinaman 
et al., 1993; Rinaman et al., 1995; Rinaman, 1999a; Maniscalco and Rinaman, 2013). A2 
neurons also are activated in a meal size-dependent manner by voluntary food intake in rats that 
have been acclimated/entrained to a feeding schedule in which repeating cycles of overnight 
food deprivation are followed by a predictable morning re-feeding period (Rinaman et al., 1998).  
Conversely, the same repeating schedule of food deprivation followed by a large anticipated 
meal does not activate GLP-1 neurons (Rinaman, 1999a), although GLP-1 neurons are activated 
in rats after a variety of interoceptive stressors (Rinaman, 1999a). Feeding schedule entrainment 
is associated with anticipatory physiological adjustments that serve to limit the homeostatic 
challenge of consuming large meals, thereby reducing the interoceptive stress that would 
otherwise be produced by the meal, and permitting increased meal size (Woods, 1991; Woods 
and Ramsay, 2000). Since multiple lines of evidence support the view that central GLP-1 
signaling suppresses food intake (Asarian et al., 1998; Hayes et al., 2009; Barrera et al., 2011; 
Zhao et al., 2012), the lack of GLP-1 neuronal recruitment in meal-entrained rats that consume a 
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large anticipated meal may reflect homeostatic adjustments that minimize interoceptive stress. 
Indeed, attenuated feeding-induced activation of GLP-1 neurons may contribute to the 
progressively larger meals consumed by rats during meal entrainment (Woods, 1991; Woods and 
Ramsay, 2000).  In non-entrained rats, such anticipatory physiological adjustments are absent, 
and deprivation-induced food intake is more directly limited by GI distension and other sensory 
feedback generated by the acute homeostatic challenge of consuming a large unanticipated meal.  
The present study was designed to test the hypothesis that both A2 and GLP-1 neuronal 
populations are recruited in non-entrained rats after voluntarily intake of a large, unanticipated 
meal. To challenge this hypothesis, we examined cFos activation among DBH- and GLP-1-
positive caudal NTS neurons in rats after deprivation-induced intake of unrestricted or restricted 
volumes of a palatable liquid diet (i.e., Ensure).  We extended our analysis of feeding-activated 
neurons to include a specific caudal subset of DBH-positive NTS neurons that co-express 
prolactin-releasing peptide (PrRP) along with NA synthetic enzymes (Chen et al., 1999; Iijima et 
al., 1999). Central PrRP signaling is implicated in stress responses and control of energy balance 
(Matsumoto et al., 2000; Maruyama et al., 2001; Samson et al., 2003; Gu et al., 2004; Ohiwa et 
al., 2007; Toth et al., 2008; Mochiduki et al., 2010; Onaka et al., 2010), and PrRP neurons may 
participate in meal size regulation (Lawrence et al., 2000; Lawrence et al., 2002; Bechtold and 
Luckman, 2006). PrRP-positive neurons within the caudal NTS are activated in experimentally 
naïve rats and mice after overnight food deprivation followed by re-feeding (Takayanagi et al., 
2008), although that report did not examine the potential relationship between the amount of 
food consumed and the extent of PrRP neuronal recruitment.  
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2.2 MATERIAL AND METHODS 
2.2.1 Animals and feeding protocol 
Experiments were conducted in accordance with the NIH Guide for the Care and Use of 
Laboratory Animals and were approved by the University of Pittsburgh Institutional Animal 
Care and Use Committee. Adult male Sprague-Dawley rats (Harlan; n=31; 200-270g BW) were 
individually housed in hanging wire cages in a temperature-controlled room with lights on from 
07:00-19:00 hr. Food (Purina rat chow #5001) and water were available ad lib, except as noted 
for each experiment. Rats were acclimated to these conditions for at least 48h before experiments 
were initiated. The test diet was liquid Ensure (Creamy Milk Chocolate or Homemade Vanilla; 
both 1.06 kcal/g; 14% protein, 64% carbohydrate, 22% fat by kcal; Abbott Nutrition, Columbus, 
OH).  A pilot study revealed no flavor-related differences in 30-min intake by rats (n=12) after 
overnight food deprivation, consistent with a previous report of similar ad lib intake of chocolate 
vs. vanilla Ensure by male Sprague-Dawley rats (Archer et al., 2006). All rats in the present 
study were pre-exposed overnight to a ball-tipped drinking spout attached to a graduated cylinder 
containing 10 ml of Ensure (in addition to chow and water) in order to reduce neophobic 
responses to the drinking spout and test diet during subsequent deprivation-induced feeding. 
Every rat consumed all of the available Ensure during this pre-exposure. In some cases, up to 5 
ml of the 10 ml provided for overnight pre-exposure was inaccessible, either because the 
drinking spout leaked (as evidenced by a small volume of dried Ensure found on the pan beneath 
the wire cage floor the next morning), and/or because the inner metal tube extended a bit higher 
than the volume remaining at the bottom of the cylinder.  Thus, pre-exposure volumes varied 
somewhat across rats, but did not vary systematically across experimental feeding groups.  
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Several days after Ensure pre-exposure, chow was removed from cages between 15:00 
and 16:00 hr; water was not removed. Twenty-four hours later, food-deprived rats were weighed 
and then given 30 min home-cage access to Ensure (the same flavor to which they had been pre-
exposed) in one of three feeding conditions, or served as food-deprived/non-fed controls, as 
follows: 
1. Unrestricted access to Ensure (i.e., rats were given access to a volume in excess of any 
rat’s 30 min intake) 
2. 30% restricted (i.e., rats were given 70% of the average volume consumed in 30 min 
by rats in the “unrestricted access” group) 
3. 50% restricted (i.e., rats were given 50% of the average volume consumed in 30 min 
by rats in the “unrestricted access” group) 
4. Food deprived/non-fed controls (i.e., no Ensure) 
Our pilot study confirmed that most food-deprived rats with unrestricted access to Ensure 
(n=12) voluntary terminated intake within the first 15 min, whereas some rats consumed a few 
more mls during the subsequent 15 min period (direct observation).  However, at the end of 30 
min, none were still actively consuming Ensure. Thus, rats with 30 min unrestricted access to 
Ensure were able to feed to satiety (i.e., as evidenced by voluntary termination of intake), 
whereas rats in the two restricted groups were limited to consuming smaller defined volumes 
during the same 30 min period. At the end of the 30 min feeding period, the amount of Ensure 
consumed by each rat was recorded and feeding bottles were removed. 
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2.2.2 Perfusion/tissue preparation 
Rats were sacrificed one hour after the end of the 30 min feeding period.  This time point was 
selected to capture peak cFos activation in response to ingestion and satiation, since cFos protein 
immunolabeling peaks 60-90 min after neural stimulation and persists at peak levels for at least 
30 additional min (Chaudhuri et al., 2000).  Rats were deeply anesthetized with pentobarbital 
sodium (Fatal Plus; 100 mg/kg BW, i.p., Butler Schein, Columbus, OH) and then transcardially 
perfused with 50-100 mL saline followed by 100 mL of 2% paraformaldehyde (PF; Sigma, St. 
Louis, MO) containing 1.5-2.0% acrolein (Polysciences Inc., Warrington, PA), followed by 100 
mL of 2% PF. After perfusion, clamps were placed at the distal esophagus and proximal 
duodenum, stomachs were excised, and gastric contents removed and weighed. Brains were post-
fixed overnight in situ in 2% PF at 4oC, then removed from the skull, blocked, cryoprotected in 
20% sucrose, frozen and sectioned at 35 μm using a sliding microtome.  Sections were collected 
serially in six sets that each contained a complete rostrocaudal series of sections spaced by 210 
μm.  Sections were stored at -20°C in cryoproservant solution (Watson et al., 1986) to await 
immunohistochemical processing.   
 
2.2.3 Immunohistochemistry 
Tissue sections were removed from cryopreservant, rinsed in 0.1 M phosphate buffer (PB, pH 
7.2), pre-treated in 0.5% sodium borohydride (Sigma) solution for 20 min, rinsed in PB, 
immersed in 0.5% H202 for 10 min, and rinsed again in PB. Primary and secondary antisera were 
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diluted in PB containing 0.3% Triton X (Sigma), 1% donkey serum (Jackson ImmunoResearch, 
West Grove, PA), and (when noted) 1% bovine serum albumin (BSA; Sigma).  
For dual cFos and GLP-1 immunolabeling, one set of pre-treated sections from each rat 
was incubated overnight in rabbit anti-GLP-1 at room temperature, using one of two primary 
antisera that yielded similar GLP-1 neural labeling (Peninsula Laboratories, San Carlos, CA, #T-
4057, 1:8000 with BSA, or Peninsula #T-4363, 1:10000, no BSA). After rinsing, sections were 
incubated in biotinylated donkey anti-rabbit IgG (1:500; Jackson ImmunoResearch) for 1 hr at 
room temperature, rinsed, then incubated in avidin-biotin complex (Vectastain Elite reagents, 
Vector Labs, Burlingame, CA) for 1.5 hrs. After rinsing, tissue underwent an H202-catalyzed 
reaction in a solution of diaminobenzidine (DAB; Sigma) in 0.1M Tris buffer to produce a brown 
cytoplasmic GLP-1 peroxidase reaction product. GLP-1-labeled tissue was then incubated 
overnight at room temperature or for 48-72 hr at 4oC in one of two primary rabbit antisera raised 
against cFos protein: one was provided by Drs. Philip Larsen and Jens Mikkelsen, Panum 
Institute, Denmark (1:5000), and the second was purchased from EMD Chemicals (PC38, San 
Diego, CA; 1:2000). Pilot studies confirmed that both cFos antisera produced similar results, 
including similar within-animal cFos activation counts for GLP-1 neurons. To visualize nuclear 
cFos labeling, sections were rinsed, incubated overnight in CY3-conjugated donkey anti-rabbit 
IgG (1:300, Jackson Immunochemicals), and rinsed again to produce an immunofluorescent 
signal.  
For triple immunolabeling of cFos, dopamine beta hydroxylase [DBH; to identify all A2 
and C2 neurons within the caudal NTS; (Rinaman, 2011)], and PrRP, an adjacent set of pre-
treated tissue sections from each rat was incubated in rabbit anti-cFos (1:20,000; EMD 
Chemicals) followed by donkey anti-rabbit IgG and avidin-biotin reagents, as described above. 
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After rinsing, tissue underwent an H202-catalyzed reaction in a solution of 0.1M sodium acetate 
buffer containing DAB and 2.5% nickel sulfate (Sigma) to produce a blue/black nuclear cFos 
peroxidase reaction product. Reacted sections were then rinsed and incubated in a cocktail of 
rabbit anti-PrRP (#H-008-52, 1:1000, Phoenix, Burlingame, CA) and mouse anti-DBH 
(#MAB308, 1:5000, Millipore, Billerica, MA) primary antisera overnight at room temperature. 
After rinsing, sections were incubated overnight at 4oC in a cocktail of CY3-conjugated donkey 
anti-rabbit IgG and Alexa 488-conjugated donkey anti-mouse IgG (both at 1:300, Jackson 
ImmunoResearch).  
After immunocytochemical processing, labeled tissue sections were rinsed in PB and 
mounted onto adhesion Superfrost Plus Microscope Slides (Brain Research Laboratories, 
Waltham, MA), allowed to dry, then dehydrated and defatted in a series of graded ethanols 
followed by xylene. Slides were coverslipped with Cytoseal 60 mounting medium (Fisher 
Scientific, Pittsburgh, PA) and stored at room temperature in covered boxes.  
 
2.2.4 Quantification of feeding-induced neural activation  
 3.2.4a. GLP-1 neural activation: GLP-1 immunoperoxidase and cFos immunofluorescent 
labeling was visualized using an Olympus BX51 microscope equipped with brightfield and 
epifluorescence (X-Cite 120) optics. In each rat, all GLP-1 neurons within the caudal NTS were 
photographed in sections (spaced by 210 μm) from the upper cervical spinal cord through the 
mid-level of the area postrema using a 20X objective and a Hamamatsu camera. GLP-1 neurons 
within the MRF were not included in cell counts. Photographs of GLP-1 neurons were uploaded 
into Adobe Photoshop, and were identified visually on a computer screen based on brown 
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cytoplasmic peroxidase labeling that was clearly perikaryal, rather than dendritic or axonal. By 
overlaying the brightfield channel (containing visible GLP-1 neurons) and the fluorescent 
channel, GLP-1 neurons were further classified as cFos-positive if their nucleus contained visible 
fluorescent cFos immunolabeling, regardless of intensity (see Figure 4). GLP-1 neuronal 
activation was quantified as the proportion (percent) of GLP-1-positive NTS neurons that also 
were cFos-positive.  
 
3.2.4b. Activation of DBH+PrRP-positive (PrRP-positive) and DBH+PrRP-negative (PrRP-
negative) neurons: DBH and PrRP dual immunofluorescence and cFos immunoperoxidase 
labeling was visualized using epifluorescence and brightfield optics. In photographs from each 
animal, DBH-positive neurons were identified and counted within the caudal NTS from the 
upper cervical spinal cord through sections just rostral to the area postrema, where the NTS 
remains immediately adjacent to the wall of the 4th ventricle. DBH-positive neurons were further 
classified as PrRP-positive or PrRP-negative based on the presence or absence of dual 
DBH+PrRP immunofluorescent labeling, and were identified as cFos-positive when their 
nucleus contained visible blue-black immunoperoxidase labeling, regardless of intensity (see 
Figure 4).  As previously reported (Chen et al., 1999), all PrRP-positive NTS neurons also were 
DBH-positive, whereas many DBH-positive NTS neurons were PrRP-negative, especially in 
sections through and rostral to the rostral area postrema. 
 
2.2.5 Data Analysis  
Analyzed data included the amount of Ensure consumed by each rat (expressed as volume, and 
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also as weight, with the latter converted to %BW), the postmortem weight of gastric contents, the 
percentage of the consumed amount and the total volume of Ensure that emptied from the 
stomach before gastric contents were collected post-perfusion, and the proportions of identified 
neurons (i.e., GLP-1, PrRP-positive, and PrRP-negative) activated to express cFos. Data are 
presented in graphs and tables as group mean ± SE. Statistically significant effects of feeding 
group on experimental outcomes were identified using ANOVA, with feeding group as the 
independent variable, followed by post-hoc LSD T-tests. Differences were considered 
statistically significant when p < 0.05.  Correlational analyses also were performed to examine 





The number of rats per feeding condition group is indicated in Table 1.  ANOVA confirmed no 





Table 1:  Meal-related statistics in non-entrained rats on the final test day  
Bodyweights, meal-related data, and gastric content data for each of the four feeding condition 
groups. Values represent group mean ± SE. Different superscript letters (i.e., a, b, c) indicate 
significant difference between groups within a column as determined by ANOVA and post-hoc 


































Unrestricted (n=10) 230.10 ± 6.49a 9.00 ± .84a 4.74 ± .50a 9.54 ± .89a 6.47 ± .79a 66.98 ± 3.43a 2.98 ± .20a 
30%restricted (n=6) 217.67 ± 4.40a 7.00 ± .13b 3.15 ± .06b 7.42 ± .14b 4.38 ± .24b 62.04 ± 4.74a 2.62 ± .34a 
50%restricted (n=8) 232.13 ± 4.58a 4.28 ± .48c 2.13 ± .15b 4.50 ± .49c 1.34 ± .27c 30.63 ± 4.00b 2.95 ± .37a 





2.3.1 Meal sizes and post-mortem gastric contents  
Except for pre-meal BW, all meal-related statistics listed in Table 1 showed an overall effect of 
feeding condition as determined by one-way ANOVA (p < .001 for all meal-related statistics). 
Rats within the unrestricted feeding group consumed approximately 4.7% of their BW within 30 
min, whereas rats in the 30% and 50% restricted feeding groups consumed approximately 3.2% 
and 2.1% of their BW, respectively (Table 1). These intake amounts corresponded to 
approximately 9.5 kcal in the unrestricted group, 7.4 kcal in the 30% restricted group, and 4.5 
kcal in the 50% restricted group (Table 1). Rats did not consume water during the Ensure re-
feeding period.  There were no flavor-related (i.e., chocolate vs. vanilla) differences in intake 
within any group. All rats in the unrestricted group had excess available but unconsumed Ensure 
remaining after the end of the 30 min feeding period, whereas all rats in the two restricted 
feeding groups consumed the entire volume of available Ensure.  The post-mortem weight of 
gastric contents (collected 1h after the end of the 30-min feeding period) ranged from 
approximately 1.3 to 6.5 g, Table 1).  Only ~31% of Ensure consumed by rats in the 50% 
restricted feeding group remained within the stomach post-perfusion, whereas ~62% of the 
consumed amount remained in the 30% restricted feeding group, and ~67% remained in the 
unrestricted feeding group. However, the absolute volume of Ensure that emptied from the 
stomach was similar across feeding groups (~2.6-3.0 ml, Table 1), as expected based on previous 




2.3.2 Feeding-induced neuronal activation 
Relatively few GLP-1 or DBH+ neurons were cFos-positive in unfed control rats, whereas cFos 
labeling increased within both neuronal populations in rats that were allowed to feed (Figs. 5 and 
6). ANOVA revealed a significant main effect of feeding condition on the proportion of GLP-1-
positive neurons expressing cFos [F(3, 27) = 12.02, p <  0.001], the proportion of PrRP-positive 
neurons expressing cFos [F(3, 25) = 40.70, p <  0.001], and the proportion of PrRP-negative 






Figure 4. Examples of GLP-1+cFos and DBH+PrRP+cFos immunolabeling in cNTS  
GLP-1-positive (B) and PrRP-positive (C) neurons within the cNTS (region indicated by red 
arrow in panel A) are activated to express cFos in representative rats that consumed an 
unrestricted (B) or 30% restricted (C) Ensure meal after food deprivation.  White arrows point 
out some of the double-labeled neurons visible within each photomicrograph, in which nuclear 
cFos immunolabeling is co-localized with cytoplasmic GLP-1 or DBH+PrRP immunolabeling. 
Brain schematic image in panel A adapted from (Swanson, 2004). Scale bars in B and C = 50 
μm. 
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2.3.3 GLP-1 neuronal activation   
The proportion of GLP-1-positive neurons expressing cFos within each feeding condition group 
is presented in Figure 5.  There was no main effect of feeding condition on the number of 
identified GLP-1-positive neurons per section ([F(3, 27) = 1.52, p = 0.23). Very few GLP-1 
neurons were cFos-positive in non-fed control rats (n=7), or in rats that were allowed to consume 
either 50% restricted (n=8) or 30% restricted volumes of Ensure (n=6; Figure 5).  Conversely, 
approximately 28% of GLP-1 neurons were c-Fos-positive in rats that consumed unrestricted 
volumes of Ensure (n=10; Figure 5).  Post-hoc analyses revealed no between-group differences 
in GLP-1 cFos activation among non-fed controls (1.95% ± 0.75), 30% restricted (0.90% ± 
0.52), and 50% restricted (2.00% ± 0.58%) groups.  The proportion of GLP-1 neurons expressing 
cFos in rats consuming unrestricted volumes of Ensure (27.57% ± 6.11) was significantly greater 
than in each of the other three groups (p < 0.001 for each comparison). Thus, intake of only a 
satiating, unrestricted volume of Ensure was sufficient to activate GLP-1 neurons above levels 
quantified in non-fed control rats, even though rats in the 50% and 30% restricted feeding 
condition groups consumed 2-3% of their BW during the 30-min feeding period, and even 
though similar volumes of Ensure had emptied from the stomach into the small intestine in rats 
from all three feeding groups (Table 1).  




Figure 5. GLP-1 neuronal activation in meal-entrained rats 
Percentage of GLP-1-immunopositive cNTS neurons that express cFos immunoreactivity in 
response to meals of increasing size (see Table 1). Different letters indicate statistically 
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2.3.4 Activation of PrRP-positive and PrRP-negative neurons  
Tissue sections were damaged in two rats (one from the 50% restricted group, one from the 
unrestricted group) that were included in GLP-1 activation analyses, and thus these two rats did 
not contribute data for analysis of DBH-positive neurons.  There was no main effect of feeding 
condition on the number of identified DBH-positive neurons per section that were PrRP-positive 
([F(3, 24) = 0.72, p = 0.55) or PrRP-negative ([F(3, 24) = 2.73, p = 0.07).  In non-fed control 
rats (n=7), DBH-positive neurons expressed very little cFos regardless of PrRP phenotype 
(0.37% ± 0.28 of PrRP-positive neurons and 1.36% ± 0.23 of PrRP-negative neurons; Figure 6).  
Similarly low activation of DBH-positive neurons was observed in the 50% restricted intake 
group (2.36% ± 1.70 of PrRP-positive and 3.29% ± 1.19 of PrRP-negative neurons; n=7). 
However, unlike the negligible GLP-1 activation observed in the 30% restricted feeding group, 
both phenotypic subpopulations of DBH-positive neurons displayed significantly increased cFos 
expression in rats consuming a 30% restricted volume of Ensure (n=6; 18.48% ± 6.06 of PrRP-
positive neurons, and 10.06% ± 1.27 of PrRP-negative neurons; p < 0.01 compared to activation 
of each DBH population in 50% restricted or non-fed control rats; Figure 6). Feeding-induced 
activation of PrRP-positive neurons was more markedly increased in the unrestricted feeding 
condition group (n=9; 43.92% ± 10.68; Figure 6), and was significantly greater in the 
unrestricted feeding group compared to each other feeding group (p < 0.01 for each comparison). 
Among PrRP-negative neurons, cFos activation in unrestricted rats (13.24% ± 1.42) was similar 
to activation of the same phenotypic neural population in rats consuming a 30% restricted meal 
(Figure 6).  
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Figure 6. A2 neuronal activation in non-entrained rats 
Percentage of DBH-immunopositive neurons, either PrRP-positive or PrRP-negative, that 
express cFos immunoreactivity in response to meals of increasing size (see Table 1). Within each 
phenotypic subgroup of DBH-positive neurons, different letters indicate significant differences 
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2.3.5 Correlational analyses 
The amount of Ensure consumed by individual rats (expressed as % BW) across all three feeding 
condition groups (i.e., excluding non-fed controls) was positively and significantly correlated 
with the proportion of GLP-1 neurons expressing cFos (Pearson’s R = 0.83; p < 0.001), with the 
proportion of PrRP-positive neurons expressing cFos (Pearson’s R = 0.81; p < 0.001), and with 
the proportion of PrRP-negative neurons expressing cFos (Pearson’s R = 0.61, p = 0.002).  In 
addition, the proportion of GLP-1-positive neurons that expressed cFos was significantly 
correlated with the proportion of PrRP-positive neurons that expressed cFos across all three 
feeding conditions (Pearson’s R = 0.71; p < 0.001).  Since the Ensure volumes consumed by rats 
in the 50% and 30% restricted feeding condition groups were artificially limited to a 
predetermined amount, additional correlations between Ensure volumes consumed and cFos 
activation were performed separately for rats within the unrestricted group alone, whose intake 
volumes were larger but also more variable within the group (Figures 6 and 7).  Once again, 
strong positive correlations were observed between the amount of Ensure consumed by each rat 
and the corresponding activation of GLP-1 neurons (Figure 7; Pearson’s R = 0.74; p < .001) and 
PrRP-positive neurons (Figure 8; Pearson's R = 0.75; p = 0.02).  The correlation between amount 
of Ensure consumed and activation of PrRP-negative neurons was not significant (Pearson's R = 
0.12; p = 0.76), nor was the correlation between activation of PrRP-positive neurons and 









Figure 7. Meal size and activation of GLP-1-positive neurons in non-entrained rats 
Relationship between meal size and percentage of GLP-1-positive neurons activated to express 
cFos in rats that consumed unrestricted, satiating volumes of Ensure (black dots). Data points 
representing non-fed controls (n=7) are added for comparison (open squares). Each symbol 
represents one animal. Best-fit line and correlation statistics refer only to rats in the unrestricted 
feeding group.  




Figure 8. Meal size and activation of PrRP-positive neurons in non-entrained rats 
Relationship between meal size and percentage of PrRP-positive neurons expressing cFos in rats 
that consumed unrestricted, satiating volumes of Ensure (black dots). Data points representing 
non-fed controls (n=7) are added for comparison (open squares). Each symbol represents one 
































Pearson's R = 0.75 
p = 0.02 
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2.4 DISCUSSION 
Results from the present study demonstrate that DBH-positive neurons within the caudal visceral 
NTS (including primarily the A2 cell group, but also the caudal portion of the C2 cell group) are 
progressively recruited to express cFos in rats that consume progressively larger volumes of 
palatable liquid Ensure after first-time food deprivation. Among DBH-positive neurons 
examined in our study, the PrRP-positive subset was most sensitive to feeding-induced 
activation, although smaller proportions of PrRP-negative neurons also were recruited when rats 
consumed large volumes of Ensure. The only previous report on feeding-induced activation of 
PrRP-positive NTS neurons (Takayanagi et al., 2008) did not examine the relationship between 
amount consumed and neuronal recruitment.  In the present study, food-deprived rats had to 
consume at least 3.1% of their BW within a 30 min period in order to significantly increase cFos 
expression by DBH-positive cNTS neurons. Notably, however, significant feeding-induced 
activation of GLP-1 neurons occurred only in the unrestricted feeding group, in which rats 
consumed very large volumes of Ensure that corresponded to nearly 5% of their BW.  Maximal 
activation of the PrRP-positive subset of DBH neurons also was achieved in the unrestricted 
feeding group.  We interpret these results as evidence that progressive recruitment of A2/C2 
neurons within the caudal NTS, especially the most caudally-situated PrRP-positive subset of A2 
neurons, effectively “tracks” the magnitude of GI signals and other meal-related sensory 
feedback.  Conversely, only the largest meals are sufficient to activate GLP-1 neurons.  Based on 
these and other published results (discussed further, below), we posit that GLP-1 neurons are 
relatively insensitive to normal, progressively increasing GI signals during food intake, but are 
ultimately recruited in response to interoceptive stress generated by the homeostatic challenge of 
consuming a very large, unanticipated meal.  Our findings are consistent with several "loss-of-
  45 
function" studies that have implicated both GLP-1 and DBH/PrRP neuronal populations in meal 
size control (Grill and Kaplan, 1992; Bechtold and Luckman, 2006; Takayanagi et al., 2008; 
Hayes et al., 2009; Barrera et al., 2011).  However, many cFos-positive cNTS neurons in the 
present study were not immunopositive for either GLP-1 or DBH/PrRP.  We do not discount the 
potential contributions of these phenotypically unidentified neurons to meal termination.  
Previous reports from our laboratory and others indicate that NA and GLP-1 neurons are 
activated to express cFos in rats after a variety of treatments that stimulate vagal sensory inputs 
to the caudal NTS (Rinaman et al., 1998; Rinaman, 1999a; Vrang et al., 2003; Gaykema et al., 
2009; Maniscalco and Rinaman, 2013). In one of these studies, we examined the ability of food 
intake to activate tyrosine-hydroxylase (TH)-positive catecholamine neurons (which include but 
are not limited to NA neurons) within the caudal NTS (Rinaman et al., 1998).  However, that 
study employed a different experimental paradigm, in which rats were acclimated for 5 days to a 
feeding schedule that included repeating cycles of overnight food deprivation followed by daily 
1 h access to unrestricted amounts of solid or liquid diet.  On day 5, rats were killed 30 min after 
the end of the 1 h feeding period, during which they consumed unrestricted or rationed amounts 
of food (Rinaman et al., 1998). Despite the different feeding paradigms utilized in that study and 
the present one, feeding-induced activation of TH-positive NTS neurons in the earlier study was 
similar to feeding-induced activation of DBH-positive neurons in the present study:  
progressively larger proportions of TH-positive NTS neurons expressed cFos in rats that 
consumed progressively larger amounts of food, with peak activation of TH neurons reaching 
~30-40% in rats that consumed an unrestricted (satiating) amount of food (Rinaman et al., 1998).  
Conversely, in a follow-up study (Rinaman, 1999a) using tissue sections from the same meal-
entrained rats, we found that GLP-1 neurons were not activated after scheduled feeding, even in 
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rats that consumed liquid diet volumes that were 2-3 times greater than those consumed by non-
entrained rats in the present study.  GLP-1 neurons were, however, activated in rats after several 
“interceptive stress” treatments, including i.p. injection of lithium chloride, lipopolysaccharide, 
or a high dose of CCK (Rinaman, 1999a).   
Considered together with the present results in rats that were not entrained to consume 
large meals, these findings support the view that GLP-1 neurons are recruited by significant 
homeostatic challenges, including the challenge generated by consuming a large unanticipated 
meal (Shiraishi et al., 1984; Woods, 1991; Woods and Ramsay, 2000). However, in the present 
study, the average proportion of GLP-1 neurons expressing cFos in rats that consumed 
unrestricted meals after 24 hr food deprivation (~28%) is only slightly elevated above the ~20% 
of GLP-1 neurons that express cFos under “baseline”, ad lib feeding conditions (Maniscalco and 
Rinaman, 2013). Thus, our results could be interpreted as evidence that after food deprivation, 
only large satiating meals of Ensure are sufficient to restore GLP-1 activation to "baseline" levels 
observed in rats maintained under ad lib feeding conditions.  
We can only speculate as to what feature of the consumed meal serves as the primary 
stimulus for NA/PrRP and GLP-1 neural activation in the present study.  Although rats in each 
feeding group consumed different volumes of Ensure, and thus different amounts of fat, protein, 
and carbohydrate calories, statistically similar volumes of consumed Ensure (~ 3 ml) had 
emptied from the stomachs in all three feeding groups by the time of perfusion. Therefore, 
differences in intestinal and post-absorptive nutrient signaling are unlikely to contribute to 
between-group differences in cFos activation.  Most of this cFos activation was contained within 
the medial and commissural subdivisions of the caudal NTS, where distension-sensitive gastric 
and intestinal vagal afferents terminate (Zhang et al., 1995; Travagli et al., 2006). Thus, we posit 
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that between-group differences in DBH/PrRP and GLP-1 neuronal activation reflect different 
degrees of GI distension coded by vagal sensory inputs to the caudal NTS, where the majority of 
DBH-positive NA neurons (A2 cell group) are PrRP-positive. Since rats within each feeding 
group consumed different volumes of Ensure, we cannot rule out potential contributions of 
differential magnitude or duration of oral sensory and motor stimuli to between-group 
differences in cFos activation. However, our previous study (Rinaman, 1999a) demonstrated 
very low activation of GLP-1-positive neurons and similar activation of DbH-positive neurons in 
food-entrained rats that consumed liquid meals that were much larger than those in the present 
study, with more concurrent oral sensory and motor stimulation. Therefore, the contribution of 
oral sensory and motor signals to cFos expression within the caudal NTS is likely minimal in the 
present study. 
In more rostral sections through the rostral area postrema, increasing numbers of PrRP-
negative neurons likely include C2 neurons that are intermingled among A2 neurons at this level, 
and rostral to the area postrema, the large majority of DBH-positive neurons are C2 neurons that 
are PrRP-negative (Chen et al., 1999; Roland et al., 1999)]. Given the extreme gastric distension 
produced by intake of unrestricted Ensure meals, recruitment of visceronociceptive spinal 
afferents might contribute to increased activation of A2 and GLP-1 neurons within the caudal 
NTS. Indeed, some of the NTS cFos expression induced by inflation of a gastric balloon is 
attributable to spinal sensory afferents (Traub et al., 1996), and the spinosolitary tract conveys 
viscerosensory activation from the spinal dorsal horn to the cNTS (Menétrey, 1987, 1990).  
Previous anatomical and functional reports demonstrate an important role for brainstem 
circuits in generating and modulating the motoric aspects of feeding (e.g., licking, chewing, 
swallowing) and accompanying vagal autonomic adjustments of GI motility and secretion 
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(Rogers et al., 2003; Hermann et al., 2005; Travagli et al., 2006; Pearson et al., 2007; Rinaman, 
2011; Llewellyn-Smith et al., 2013). Decerebrate rats that lack brainstem-forebrain 
communication still exhibit satiation (Section 1.2) (Grill and Norgren, 1978a; Grill and Smith, 
1988; Grill and Kaplan, 1992), demonstrating that isolated brainstem circuits are sufficient for 
meal termination. Our own unpublished data identify PrRP- and GLP-1-immunoreactive fibers in 
brainstem regions that control somatic motor and autonomic aspects of feeding, including the 
DVC, parabrachial nucleus, more rostral (taste) regions of the NTS, and the medullary and 
pontine reticular formation.  It currently is unknown whether GLP-1 or PrRP-immunoreactive 
terminals are synaptically linked to brainstem neurons that control feeding behavior, but this 
question is ripe for experimental analysis.  
 Our results demonstrate that large satiating meals of palatable liquid Ensure recruit NA 
(especially PrRP-positive) and GLP-1-positive neurons within the caudal NTS in rats that have 
not been acclimated/entrained to a feeding schedule.  Conversely, we previously reported that 
large meals activate similar proportions of NA neurons but do not activate GLP-1 neurons in 
meal-entrained rats (Rinaman et al., 1998; Rinaman, 1999a). Considered together, these findings 
support the conclusion that PrRP-positive A2 neurons are progressively recruited during feeding 
as a function of meal size, regardless of prior meal entrainment history, whereas GLP-1 neurons 
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3.0  HINDBRAIN GLP-1 NEURONS TRACK INTAKE VOLUME AND PROMOTE 
SATIATION IN MEAL-ENTRAINED RATS 
3.1 INTRODUCTION 
Food intake is regulated by a complex, neurochemically diverse neural networks distributed 
within the brainstem, hypothalamus, and limbic forebrain. Food intake is the product of meal 
number (determined by signals that initiate feeding bouts) and meal size (determined by signals 
that terminate feeding bouts) (Smith, 1996). When rats in a controlled laboratory environment 
have unlimited access to standard chow, meal size is largely determined by feeding-generated 
satiety signals arising from the GI tract that are delivered by vagal sensory inputs to the cNTS 
(Grill and Norgren, 1978a; Grill and Smith, 1988; Appleyard et al., 2007; Grill and Hayes, 2009; 
Hayes et al., 2009; Grill, 2010; Hisadome et al., 2011). The cNTS relays satiety signals to a 
variety of central regions, including brainstem pattern generator and pre-motor circuits that 
control the motoric components of feeding (i.e., licking, chewing, and swallowing) (Smith, 2000; 
Travers and Rinaman, 2002). While it is clear that the cNTS is critically involved in receiving 
and processing signals that modulate ingestive consummatory behaviors, details regarding the 
neurochemical identity and circuit connectivity of cNTS neurons that limit meal size are just 
beginning to emerge.  
Recent studies support the hypothesis that GLP-1-immunopositive cNTS neurons 
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participate in meal termination. In rats, GLP-1 neurons are activated to express the immediate-
early gene product cFos in response to experimental treatments that reduce meal size, including 
restraint stress (Calvez et al., 2011; Maniscalco, 2014), i.p. injection of CCK (West et al., 1984; 
Rinaman, 1999a; Maniscalco and Rinaman, 2013), or gastric distension (Davis and Campbell, 
1973; Vrang et al., 2003).  Our recently published study explored whether food intake itself 
activated cFos expression by GLP-1 neurons (Kreisler et al., 2013).  In that study rats were food 
deprived for 24 hours for the first time and then allowed to re-feed to satiety on palatable liquid 
Ensure. Although rats consumed approximately 5% of their body weight within 30 min, these 
large, satiating liquid meals activated cFos expression in only ~30% of GLP-1 neurons (Kreisler 
et al., 2013). By comparison, approximately 20% of GLP-1 neurons express cFos under baseline 
conditions in non-treated, ad lib-fed control rats (Maniscalco and Rinaman, 2013).  Since the 
proportion of GLP-1 neurons expressing cFos was significantly and positively correlated with 
intake volume (Kreisler et al., 2013), we hypothesized that rats consuming even larger volumes 
would display proportionately higher levels of GLP-1 neural activation. To challenge this 
hypothesis, the first experiment in the present study examined GLP-1 neural activation in rats 
that were trained over 5 days to consume significantly larger volumes within a 1 h period, which 
activated up to 90% of GLP-1 neurons (see Section 4.4). 
The progressive increase in GLP-1 neuronal activation assessed in rats after intake of 
progressively larger volumes suggests that GLP-1 neurons participate in the process of satiation. 
However, it also is possible that GLP-1 neurons are simply tracking gastric distension or some 
other feeding-related sensory signal, without actively participating in meal size control. Support 
for a role of GLP-1 neural signaling in satiation has been equivocal. Pharmacological antagonism 
of central GLP-1 receptors in rats by i.c.v. infusion of Ex9 has been reported to increase 
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cumulative intake in some feeding paradigms (Turton et al., 1996; Hayes et al., 2009; Williams 
et al., 2009; Dossat et al., 2011; Alhadeff et al., 2012), but not in others (Turton et al., 1996; 
Hayes et al., 2009; Williams et al., 2009; Alhadeff et al., 2012). For example, Ex9 administered 
into the 4th ventricle increased chow intake compared to intake by vehicle-injected rats, but only 
after rats had first consumed 9 ml of Ensure (Hayes et al., 2009). Intake by non-injected rats was 
not reported in that study, making it unclear whether GLP-1 receptor antagonism increased 
baseline intake or simply countered a hypophagic effect of handling or i.c.v. vehicle injection.  
Similarly, another group reported convincing evidence that i.c.v. Ex9 dose-dependently increases 
cumulative dark-onset food intake in ad lib-fed rats (Dossat et al., 2011), although comparable 
intake by the same rats under non-injected baseline conditions was not reported.  In another set 
of studies, rats that were food-deprived for the first time subsequently consumed the same 
amount of chow regardless of whether they were pretreated i.c.v. with Ex9 or vehicle before 
refeeding (Turton et al., 1996; Williams et al., 2009). Of all the published studies that have 
examined food intake in rats after central administration of Ex9, only one has reported an effect 
of Ex9 to increase meal size (Dossat et al., 2013). However, that study also did not report 
comparable intake data from non-injected rats, and did not report whether the Ex9-induced 
increase in meal size resulted in increased cumulative intake. 
Based on the differential ability of smaller (Chapter 3) vs. larger (present study) satiating 
liquid meals to activate cFos expression by GLP-1 neurons, we hypothesized that endogenous 
central GLP-1 receptor signaling might contribute to satiation only when food is consumed in 
excess of homeostatic need. To explore this, we administered Ex9 or vehicle i.c.v. to ad lib-fed 
rats that were trained to consume liquid Ensure for a limited period of time each day, and 
assessed Ex9 effects on subsequent meal-related parameters and cumulative intake. We also 
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compared baseline Ensure intake to intake in rats after vehicle or Ex9 injection in order to 
examine whether endogenous GLP-1 signaling attenuates hypophagic responses to the mild 
stress of handling and i.c.v. injection.  
3.2 MATERIAL AND METHODS 
Experiments were conducted in accordance with the NIH Guide for the Care and Use of 
Laboratory Animals and were approved by the University of Pittsburgh Institutional Animal 
Care and Use Committee. Male Sprague Dawley rats (Harlan, Indianapolis, IN) were 
individually housed in hanging wire cages in a temperature-controlled room (lights on from 
0700–1900 h), with ad lib access to food (Purina rat chow #5001) and water, unless otherwise 
noted.  Rats were acclimated to this environment for at least 3 days prior to experimental 
manipulations.  
3.2.1 Experiment 1: Feeding-induced GLP-1 neuronal activation in rats entrained to 
consume a standard liquid diet (LD) for 1 h. 
3.2.1a. Meal entrainment. Ad lib-fed rats (n = 29; 230-300g BW at time of final testing) were 
pre-exposed overnight to a ball-tipped drinking spout attached to a graduated cylinder containing 
10 ml of Ensure (Milk Chocolate flavor, 1.06 kcal/g; 14% protein, 64% carbohydrate, 22% fat by 
kcal; Abbott Nutrition, Columbus, OH) in addition to chow and water. This pre-exposure was 
performed to reduce neophobic responses to Ensure during a subsequent deprivation-induced 
feeding test in a subset of rats, described below. Every rat consumed all of the available Ensure 
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during overnight pre-exposure. While only a subset of rats was assigned to an Ensure feeding 
group on the final test day (see below), all rats were pre-exposed similarly in order to standardize 
their treatment histories.   
At least 48h later, all rats were fasted overnight (~22 hr, beginning at ~1600 hr) to initiate 
a 5-day meal-entrainment (scheduled feeding) protocol. Fasting was discontinued after this initial 
night.  On the first and subsequent days, rats received access to an excess volume of LD (0.5 
kcal/ml; 20% protein, 70% carbohydrate, 10% fat by kcal; Research Diet, New Brunswick, NJ) 
presented in their home cage for 1 h each afternoon (beginning at 1430 h), with the amount 
consumed recorded on each of the 5 acclimation days (Figure 9). Water was removed during LD 
access. On the first and subsequent days, one and a half to two hours after the end of LD access 
(17:00-17:30hr), rats were given 12-13g of chow (3.0 kcal/g) to consume overnight. Each rat 
consumed the entirety of its chow ration by the next morning on each of the 5 acclimation days. 
Rats maintained or increased their BW by up to 5g per day during the 5-day acclimation period. 
One hour LD intake and BWs were recorded daily.  
  
3.2.1b. Final treatment groups.  On day 6, meal-entrained (schedule-fed) rats were divided into 5 
experimental groups in order to examine cFos activation in meal-entrained rats consuming test 
meals of different volumes and caloric densities.  One group received their usual 1 h access to an 
unrestricted volume of LD (LD rats, n = 6). A second group received 1 h access to an 
unrestricted volume of Ensure, which was diluted by 50% with water to match the caloric density 
of LD (0.5 kcal/ml, diEN rats, n = 5). A third group received 1 h access to an unrestricted 
volume of undiluted Ensure (1.06 kcal/ml, EN rats, n = 5). A fourth group received 1 h access to 
a restricted volume of LD (RES-LD rats; n = 7), equivalent to 60% of the average LD volume 
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consumed by all rats on the previous day (i.e., on day 5 of the feeding schedule). The fifth group 
of rats was not fed during the final 1 h period (NF rats; n = 6). 
  
3.2.1c. Perfusion fixation. Thirty to 45 minutes after the end of the final 1 h feeding period, rats 
were deeply anesthetized with pentobarbital sodium (Fatal Plus; 100 mg/kg BW, i.p., Butler 
Schein, Columbus, OH) and then transcardially perfused with 50–100 ml saline followed by 100 
ml of 2% paraformaldehyde (PF, Sigma, St. Louis, MO) containing 1.5–2.0% acrolein 
(Polysciences Inc., Warrington, PA), followed by 100 ml of 2% PF. After perfusion, clamps 
were placed at the distal esophagus and proximal duodenum, stomachs were excised, and gastric 
contents removed and weighed. Brains were post-fixed overnight in situ in 2% PF at 4°C, then 
removed from the skull, blocked, cryoprotected in 20% sucrose, frozen and sectioned at 35 μm 
using a sliding microtome. Sections were collected serially in six sets such that each contained a 
complete rostrocaudal series of sections spaced by 210 μm. Sections were stored at −20°C in 
cryoproservant solution (Watson et al., 1986) to await immunohistochemical processing. 
  
3.2.1d. Immunohistochemistry. Tissue sections were removed from cryopreservant, rinsed in 0.1 
M phosphate buffer (PB, pH 7.2) and pre-treated in 0.5% sodium borohydride followed by 0.5% 
H2O2. For dual cFos and GLP-1 immunoperoxidase labeling, one set of pre-treated sections from 
each rat was incubated overnight at room temperature or for 48–72 h at 4 °C in primary rabbit 
antiserum raised against cFos protein (EMD Chemicals, San Diego, CA, #PC38; 1:20,000). After 
rinsing, sections were incubated in biotinylated donkey anti-rabbit IgG (Jackson 
ImmunoResearch, West Grove, PA; 1:500) for 1 h at room temperature, rinsed, then incubated in 
avidin–biotin complex (Vectastain Elite reagents, Vector Labs, Burlingame, CA) for 1.5 h. 
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Diaminobenzidine (DAB; Sigma) intensified with nickel sulfate was catalyzed by H2O2 to 
produce a blue-black nuclear cFos reaction product. 
After cFos immunolabeling, sections were incubated overnight in rabbit anti-GLP-1 
(Peninsula, San Carlos, CA, #T-4363; 1:10,000) at room temperature. After rinsing, sections 
were incubated in biotinylated donkey anti-rabbit IgG and then avidin–biotin complex, as 
described above. After rinsing, tissue underwent an H202-catalyzed reaction in a solution of DAB 
in 0.1 M Tris buffer to produce a brown cytoplasmic GLP-1 peroxidase reaction product.  
  
3.2.1e. Quantification of feeding-induced GLP-1 neuronal activation.  In each rat, the number of 
GLP-1 neurons within the cNTS and MRF was quantified in sections (spaced by 210 μm) from 
the upper cervical spinal cord through the mid-level of the area postrema using a 20x objective 
on a light microscope. GLP-1 neurons were classified as cFos-positive if their nucleus contained 
visible cFos immunolabeling, regardless of intensity. GLP-1 neuronal activation was quantified 
as the proportion (percent) of GLP-1-positive cNTS or MRF neurons that also were cFos-
positive.  
 
3.2.1f. Data analysis.  Analyzed data included the amount of LD, diEN, or EN consumed by 
each rat (expressed as volume, and also as weight, with the latter converted to % BW), the 
postmortem weight of gastric contents, the percentage of the consumed amount and the total 
amount of diet (expressed as kcal) that emptied from the stomach before gastric contents were 
collected post-perfusion, and the proportions of identified GLP-1 neurons activated to express 
cFos within the cNTS and the MRF. Data were combined by final feeding group on day 6 and 
are presented in graphs and tables as group mean ± SE. Statistically significant effects of feeding 
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group on experimental outcomes were identified using ANOVA, with feeding group as the 
independent variable, followed by planned post-hoc Tukey t-tests (corrected for multiple 
comparisons) to detect differences between individual feeding groups. The Tukey post-hoc test 
was used because it is relatively conservative, which is appropriate given the large number of 
comparisons performed between the 6 experimental groups. Differences were considered 
statistically significant when p < 0.05. Correlational analyses also were performed to examine 
relationships between feeding-related measures and cFos activation of GLP-1 neurons.   
 
3.2.2 Experiment 2: Ensure intake after GLP-1 receptor blockade in meal-entrained rats 
This experiment was designed to evaluate the role of endogenous GLP-1 signaling in controlling 
liquid Ensure intake in meal-entrained rats.  
 
3.2.2a. Cannulation procedures. Experimentally naive, individually-housed male rats  
(n = 13, 287-308g BW at time of surgery) were anesthetized with isoflurane (1.5–2% in oxygen) 
and placed into a stereotaxic frame. Rats were fitted with a unilateral chronic indwelling 21-
gauge stainless steel guide cannula (Plastics One, Roanoke, VA) positioned above the lateral 
ventricle, 1.5 mm lateral and 0.90 mm caudal to bregma, with the tip protruding 2.7 mm below 
the surface of the skull. Cannulas were fixed to the skull with anchor screws and dental acrylic 
and fitted with removable obturators that sat flush with the tip of the guide cannula.  Correct 
cannula placement was verified 5-6 days later, after pre-surgery bodyweights were attained. For 
this purpose, water-replete rats were injected i.c.v. with 2 μl of sterile 0.15M saline (SAL) 
containing 5 ng of angiotensin II (ANGII, Sigma). All rats included in this report began drinking 
  57 
water within 30 sec and drank at least 6 ml in 30 min, evidence for accurate cannula placement 
(Johnson and Epstein, 1975). 
  
3.2.2b. Meal-entrainment protocol using lickometer-equipped feeding boxes. Beginning 2-7 days 
after the ANGII screening test, cannulated rats (now 292-344 g BW) were acclimated to a 
feeding schedule that was maintained for 7 days, as follows: from 1600-1800 h each day, rats 
were individually placed into clear Plexiglass feeding boxes (12 x 10-inch floor, 8-inch height) 
with stainless steel rod floors (Med Associates, Georgia, VT) in a room adjacent to the housing 
room. Feeding boxes contained a contact lickometer connected to a metal ball-spout and 
graduated cylinder that supplied unrestricted amounts of Ensure (0.93 kcal/ml). The volume of 
Ensure within the graduated cylinder was recorded at 0 and again at 120 min after placing the rat 
in the box. Lickometers were connected to a computer with software (Med PC) set to record the 
cumulative number of licks made by each rat every 60 sec over the 2 h feeding period. Each rat 
was placed in the same feeding box equipped with the same ball-spout each day. After each 2 h 
feeding period, rats were immediately returned to their home cages and given an excess amount 
of pre-weighed chow that they could consume ad lib overnight. Each morning (between 0900-
1000hr), remaining chow and spillage were collected and weighed to determine intake, and rat 
BWs were recorded. During daily collection of BW data, rats were gently restrained by hand and 
cannula obturators manipulated in order to acclimate rats to procedures used during subsequent 
i.c.v. injections. 
 
3.2.2c. Intracerebroventricular injections and Ensure intake. On day 7 of the feeding schedule, 
rats were randomly assigned to receive an i.c.v. infusion of either 3 μL of saline vehicle (SAL, n 
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= 7) or vehicle containing 100 μg Ex9 (Ex9, n = 6), a dose previously reported to increase food 
intake after i.c.v. infusion in adult rats compared to intake after i.c.v. vehicle under certain 
experimental conditions (Turton et al., 1996; Kanoski et al., 2011). Infusates were administered 
at approximately 1530 hr using a Hamilton syringe attached to polyethylene tubing attached to a 
26-gauge injector tip (Plastics One) that extended 2.5 mm beyond the tip of the guide cannula, to 
enter the ventricular space. After i.c.v. infusion rats were returned to their home cages for 15-30 
min, then were placed into the lickometer chambers from approximately 1600-1800 hr for 2 h 
Ensure intake as usual.  
After completing the experiment, to confirm proper i.c.v. cannula placement and patency, 
rats were deeply anesthetized with Fatal Plus, infused i.c.v. with ~5 μl of black India ink, and 
then transcardially perfused with 100-150 ml of paraformaldehyde (PF, Sigma, St. Louis, MO).  
All data included in this report were obtained from rats with visible ink at the base of the 
hypothalamus and within the cerebral aqueduct, confirming proper i.c.v. cannula placement and 
patency. 
 
3.2.2d. Data analysis 
Cumulative intake volume: The total volume of Ensure consumed by each rat (converted 
to grams and then expressed as % BW) during the 2 h feeding period was analyzed and 
compared at baseline (day 6) and after i.c.v. injection (day 7). Cumulative Ensure intake data are 
presented both as absolute intake values and as values normalized to each animal's baseline 
intake (% change from baseline). Statistically significant between-group differences in 
cumulative intake volume were determined using mixed ANOVA for absolute values and 
independent samples T-tests for normalized values.  
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Meal structure: Lick data were used to determine meal structure within each 2 h feeding 
period. Based on published criteria for rats consuming a liquid diet (West et al., 1984; Rushing et 
al., 1997; Aja et al., 2001), a meal was defined as at least three licks, while a pause of at least 5 
min between licks defined the end of the previous meal. A previous study demonstrated that 
varying the pause criterion from 2 to 60 min does not significantly change the number of meals 
detected under such experimental conditions (Rushing et al., 1997).  Analyzed data included 
meal number, meal size (# of licks), meal duration (minutes), and intermeal interval (IMI, 
minutes) during feeding under baseline (non-injected) conditions (day 6) and after either SAL or 
Ex9 injection (day 7). Statistically significant effects of i.c.v. injection on feeding parameters 
were identified using mixed ANOVA for absolute values followed by T-tests, and independent 
samples T-tests for normalized values.  
3.3 RESULTS 
3.3.1 Experiment 1: Feeding acclimation and gastric emptying of the final test meal in 
meal-entrained rats consuming LD  
Daily 1h LD intakes for all rats during the 5-day acclimation period in Experiment 1 (as volume 
and %BW) are presented in Figure 9. LD intake increased progressively between days 1 and 4 
(Figure 9), whereas intake on day 5 was not significantly different from intake on day 4 (paired-
samples T-test: t (28) = 1.27, p > 0.05).  On the final intake test and perfusion day (day 6), rats 
assigned to the LD group consumed approximately 12.9% of their BW (~ 31 ml; Figure 9, Table 
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2) within 60 min, similar to LD intake of all rats on acclimation days 4 and 5. Conversely, rats 
assigned to the diEN, EN, or RES-LD groups consumed smaller volumes (i.e., approximately 
10.7%, 8%, and 7.5% of their BW, respectively; Figure 9). No rats were still consuming food 
when bottles were removed at the end of the 1 h feeding period. At the time of perfusion (30 min 
after the end of the 1 h feeding period), post-mortem gastric content assessment indicated that 
more calories had emptied from the stomach into the intestines in LD and diEN rats (~9.8 and 
9.3 kcal, respectively; Table 2) compared to calories emptied in EN and RES-LD rats (~6.8 and 
7.2 kcal, respectively; Table 2).  
  





Figure 9. Average daily 1 h LD intake during the meal-entrainment acclimation period and 
on the final test day in Experiment 1.  
Data from all 29 rats in the experiment are represented for each acclimation day (days 1-5). 
There was no significant difference in 1 h intake volume between days 4 and 5 (paired-samples 
T-test, p > .05). On day 6, rats were randomly assigned to one of five feeding or non-fed 
conditions, as indicated (colored symbols). Intake values (%BW) are indicated at each data point, 
and represent the average group intake on that day. 
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Table 2. Meal-related statistics in meal-entrained rats on the final test day (Experiment 1)  
Values represent group mean ± SE. Different superscript letters indicate significant differences 
between groups within a column, as determined by one-way ANOVA with Tukey HSD post-hoc 
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3.3.1a. Feeding-induced activation of GLP-1 neurons in meal-entrained rats. As expected, there 
was no main effect of feeding condition on the number of GLP-1-positive neurons counted 
within either the cNTS [66.69 ± 5.08 neurons per rat; between-groups comparison F(4, 24) = 
1.82, p > 0.05] or the MRF [54.41 ± 3.95 neurons per rat; between-groups comparison F(4, 24) 
= 0.95, p > 0.05].  Also as expected, very few GLP-1-positive neurons in either medullary region 
were cFos-positive in NF rats, whereas cFos expression by GLP-1 neurons in both regions was 
increased in rats within all four fed groups (Figure 10). GLP-1 neural activation within the cNTS 
in a representative rat from the LD group is shown in Figure 11.  ANOVA revealed a significant 
main effect of feeding condition on the proportion of GLP-1 neurons expressing cFos within the 
cNTS [F(4, 24) =37.62, p < 0.001] and MRF [F(4, 24) =11.98, p < 0.001]. Within the cNTS, the 
proportion of GLP-1 neurons activated to express cFos in RES-LD rats was significantly higher 
than the proportion activated in NF rats (Figure 10).  Within the MRF, however, the difference in 
GLP-1 activation between NF and RES-LD groups was not significant (p = 0.64). Interestingly, 
significantly larger proportions of cNTS GLP-1 neurons were activated in all four fed groups 
compared to activation of GLP-1 neurons within the MRF (p < 0.05 for each within-feeding 
group comparison; Figure 10). Among the three groups that consumed unrestricted (i.e., 
satiating) amounts of EN, diEN, or LD, there were no between-groups differences in activation 
of GLP-1 neurons within either the cNTS or within the MRF (p > 0.05 for each between-group 
comparison; Figure 10).  
An adjacent tissue set from each meal-entrained rat was dual immunolabeled for PrRP 
and cFos. The proportion of PrRP-positive neurons in cNTS that express cFos is presented for 
each of the five feeding conditions in Appendix A. 
 




Figure 10. GLP-1 neuronal activation in meal-entrained rats 
Percentage of GLP-1-immunopositive neurons that express cFos immunoreactivity in rats 
consuming meals of different sizes or types (Experiment 1). GLP-1 neurons within the cNTS 
(black bars) and medullary reticular formation (MRF; open bars) are presented separately. 
Within each regional subgroup of GLP-1 neurons, different letters indicate significant 












Figure 11. Example of GLP-1 and cFos dual immunolabeling in cNTS 
GLP-1-positive (B; brown peroxidase labeling) neurons within the cNTS (region indicated by 
black arrow in panel A) are activated to express cFos (B; purple/black nuclear labeling) in a 
representative rat that consumed 14% of its BW in LD (Experiment 1). Black arrows in B point 
out some of the double-labeled neurons in which nuclear cFos immunolabeling is co-localized 
with cytoplasmic GLP-1. White arrow in A indicates the MRF, where additional GLP-1-positive 
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neurons reside. Scale bar in B = 50 μm. Brain schematic image in panel A adapted from 
(Swanson, 2004). 
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3.3.1b. Correlational analyses of GLP-1 neuronal activation vs. amount consumed. Figure 12 
plots the grams of test diet consumed by individual rats (expressed as % BW) compared to cFos 
activation of cNTS GLP-1 neurons across all feeding groups in Experiment 1. For purposes of 
comparison, food intake (as % BW) and GLP-1 cFos activation data from our recently published 
study (Kreisler et al., 2013, Chapter 3) using non-entrained rats that consumed unrestricted 
amounts of Ensure also are plotted in Figure 12.  In that earlier study, experimentally naïve rats 
that were fasted overnight and then re-fed for the first time consumed, on average, 4.7% BW of 
Ensure and displayed cFos activation of ~27.5% of cNTS GLP-1 neurons (Figure 5). Across both 
studies, activation of cNTS GLP-1 neurons was positively (Pearson's R = 0.86) and significantly 
(p < 0.001) correlated with amount consumed (as % BW) across all 5 experimental fed groups 
(note that Entrained: NF group data are plotted in Figure 12 but are not included in correlational 
analysis). When only entrained (refed) rats in the present study are considered, activation of 
cNTS GLP-1 neurons was also positively (Pearson's R = 0.82) and significantly (p < 0.001) 
correlated with amount consumed (as %BW). An adjacent tissue set from each rat was dual 
immunolabeled for PrRP and cFos. Correlational analysis between activation of cNTS PrRP 
neurons and amount consumed is presented in Appendix A.  
cFos activation of cNTS and MRF GLP-1 neurons in the present study also was 
positively and significantly correlated with the calculated value of calories emptied from the 
stomach (i.e., reaching the intestines; Table 2) by the time of perfusion (Pearson's R = 0.66, p = 
0.001 for cNTS GLP-1 activation vs. calories emptied; R = 0.60, p = 0.002 for MRF GLP-1 
activation vs. calories emptied). 
  






Figure 12. Relationship between amount consumed (as %BW) and cNTS GLP-1 neuronal 
activation in meal-entrained rats consuming different diets (Experiment 1).  
Each symbol represents one rat. Data from non-entrained, Ensure-fed rats (“Non-entrained: EN”) 
from Figure 7 are included for comparison. Data from Entrained: NF rats also are plotted for 
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3.3.2 Experiment 2: Ensure intake and meal pattern analyses in meal-entrained rats after 
central blockade of GLP-1 receptors  
Daily 2 h Ensure intake (expressed as kcal and as % BW) increased progressively during the 
acclimation period, stabilizing by day 4 (Figure 13). Overnight chow intake simultaneously 
decreased from day 1 to day 3, and then remained stable on days 4-6, resulting in stable total 
daily caloric intake for the duration of the acclimation period (Figure 13). On average, BW 
remained stable across the entire acclimation period (322g ± 3.9 on day 1 and 325g ± 4.2 on day 
6, data not shown).  
 
  





Figure 13. Daily food intake (expressed as kcal) during the meal-entrainment acclimation 
period for cannulated rats in Experiment 2.  
Data from all 13 rats are represented for each day. Paired-samples T-test revealed no significant 
difference in 2 h Ensure intakes between days 5 and 6 (p > 0.05). Experimental treatment (i.c.v. 
injections) occurred on day 7.  The indicated percentage values (inside the gray bars) are the 
average Ensure intake volume each day, expressed as %BW.  
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3.3.2a. Two hour volumetric Ensure intake: Cumulative 2 h intake data at baseline (day 6) and 
after i.c.v. injection (day 7) were expressed in two ways: 
 Absolute intake (expressed as %BW): After intake stabilization, cumulative 2 h Ensure 
intake by each rat was assessed at baseline (day 6, n = 13) and after i.c.v. infusion of Ex9 (n = 6) 
or SAL vehicle (n = 7) (Figure 14 A). There was a significant interaction between day (i.e., 
baseline or i.c.v. treatment) and injection condition (i.e., SAL or Ex9) [F (1, 11) = 5.99, p < 
0.05]. Post-hoc tests revealed that SAL- and Ex9-injected rats consumed similar volumes of 
Ensure after i.c.v. injection (6.75 %BW ± 0.47 and 6.45 %BW ± 0.12, respectively, p > .05, 
Figure 14 A). The interaction was driven by an unanticipated significant difference in day 6 
baseline intake between rats that were assigned to the i.c.v. SAL group (which consumed 6.95% 
BW ± 0.25 at baseline) and those that were assigned to the i.c.v. Ex9 group (which consumed 
5.12% BW ± 0.45 at baseline) (Figure 14 A). 
 Normalized intake (expressed as % change from baseline): Compared to their own 
individual baseline 2 h Ensure intakes, SAL-injected rats decreased their intake by 2.14% ± 7.03, 
whereas Ex9-injected rats increased their intake by 29.46% ± 8.54 (Figure 14 B). These change 
from baseline values were significantly different between i.c.v. injection groups (t (11) = -2.89, p 
< .05).  




Figure 14. Cumulative 2h Ensure intake in ad lib-fed, meal-entrained rats (Experiment 2). 
Panel A shows between-groups comparisons of cumulative intake (as %BW) by SAL- and Ex9-
injected rats (day 7), and also shows baseline intake by the same rats within each group (day 6; 
BASE-SAL and BASE-Ex9).  In panel B, cumulative 2 h intake on the i.c.v. injection day (day 
7) is normalized (within-subjects) to each rat’s own baseline intake (day 6), and then averaged 
within each i.c.v. injection group.  ns, not significantly different (T-test, p > .05); *, significantly 
different (T-test, p < .05).   
  73 
3.3.2b. Meal structure: Meal structure during each 2 h feeding period was assessed based on 
lickometer data. Data reflecting meal number, size, duration, and inter-meal interval (IMI) of 
Ensure intake by rats on baseline and i.c.v. injection days (absolute values, Table 3) also were 
normalized to each rat's own baseline Ensure intake data (% change from baseline, Table 3).  
 Absolute values. During the 2 h feeding period, rats typically consumed 2 meals 
separated by an IMI of approximately 1 h (Table 3), regardless of treatment group or condition.  
Since every rat consumed at least two meals, but only a few rats consumed a third, comparisons 
of meal size and duration were applied separately to the first and second meals. ANOVA 
revealed no significant main effects of day or injection condition on the size or duration of the 
first meal, on meal number, or on IMI (p > 0.05 for each parameter). However, while there also 
was no main effect of day on any second meal parameters, there was a significant interaction 
between day and injection condition on both the size [F (1, 11) = 6.32, p < 0.05] and duration [F 
(1, 11) = 6.45, p < 0.05] of the second meal. Post-hoc between subjects tests revealed that rats 
consumed significantly larger second meals after i.c.v. Ex9 (~2990 licks) than after i.c.v. SAL 
(~1350 licks; t(11) = -2.40, p < 0.05, Table 3). Paired within-subject comparisons revealed that, 
for SAL-treated rats, the duration of the second meal after i.c.v. injection (~4.7 min) was 
significantly reduced compared to the duration of the second meal under baseline conditions 
(~10.1 min; SAL vs. BASE-SAL values, t(6) = 2.80, p < 0.05, Table 2). The difference between 
the size of the second meal within SAL-injected rats after i.c.v. treatment (~1350 licks) 
compared to their own baseline values (~2939 licks) also trended towards statistical significance 
(p = 0.08).  Within the Ex9-treated group, however, there were no significant differences in 
absolute values for any meal-related parameter assessed on i.c.v. injection day compared to 
baseline (Table 2).   
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 Normalized values (expressed as % change from baseline): Meal structure data were 
additionally expressed as the percent change in each parameter's value after i.c.v. injection 
compared to the same rat's non-injected baseline value, then combined by injection group 
(bottom two rows, Table 3). Consistent with the comparisons of absolute intake values, the 
duration of the second meal in SAL rats after i.c.v. injection was reduced by ~46% compared to 
baseline, whereas the duration of the second meal in Ex9 rats after i.c.v. injection was increased 
by ~32% compared to baseline. These differential within-subjects effects of i.c.v. treatment were 
significantly different (t(11) = -2.23, p < .05, Table 2). Similarly, the size (in licks) of the second 
meal in SAL rats was reduced by ~40% after i.c.v. injection compared to baseline, whereas the 
size of the second meal in Ex9 rats was increased by ~47% compared to baseline (bottom two 
rows, Table 3). These within-subjects effects of i.c.v. treatment also were significantly different 
(t(11) = -2.35, p < .05, Table 3).  For all other meal parameters analyzed, the change from 
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Table 3. Meal pattern data in meal-entrained rats  
Meal pattern data on baseline (no injection; BASE-SAL, BASE-EX9) and i.c.v. injection days 
(SAL, EX9) in Experiment 2. The top four rows indicate absolute (i.e., non-normalized) values. 
Values in the bottom two rows (shaded) were generated by normalizing absolute values for each 
parameter in rats after i.c.v. injection to their own baseline values for the same parameter 
(expressed as % change from baseline).  *Absolute value significantly greater than respective 
SAL absolute value; # Absolute value significantly less than respective BASE-SAL value; $ 
Normalized value after Ex9 significantly greater than respective SAL normalized value (T-tests, 
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3.4 DISCUSSION 
The present study was designed to investigate feeding-induced recruitment of hindbrain GLP-1 
neurons in rats entrained to consume very large volumes of liquid diet, and also to explore a role 
for central GLP-1 signaling in controlling food intake under such conditions.  Our cFos results 
indicate that GLP-1 neurons are progressively recruited in rats consuming progressively larger 
volumes of liquid diet. Similar volumes of liquid diet were consumed by rats after i.c.v. injection 
of SAL or Ex9 (between-subjects comparison). However, when intake after i.c.v. injection was 
compared to intake by the same rats under non-injected baseline conditions (within-subjects 
comparison), Ex9 treatment increased cumulative 2 h intake, whereas SAL treatment had no 
significant effect on cumulative intake.  Additional insights into the effects of i.c.v. Ex9 or SAL 
on intake were gained from meal pattern analysis, which revealed that increased cumulative 
intake after Ex9 treatment was the result of larger second meals (# of licks) during the latter 
portion of the 2h feeding period. Thus, our results suggest that GLP-1 receptor signaling helps to 
limit meal size after a substantial amount of food has already been consumed. In addition, 
however, i.c.v. SAL treatment alone reduced the duration of the second meal by nearly 50% 
compared to non-treated baseline conditions.  These results highlight the importance of 
considering both cumulative intake and meal pattern data collected under both non-manipulated 
control and experimental conditions, particularly when assessing the role of stress-sensitive 
neuropeptide systems such as GLP-1 (Maniscalco et al., 2012b) in controlling food intake and 
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3.4.1. Feeding-induced activation of GLP-1 neurons: cNTS.  
 
In Experiment 1, 60-80% of GLP-1 neurons in the cNTS were activated to express cFos after rats 
ate to satiety by consuming 7-13% of their BW in liquid diet during the allotted 1h feeding 
period (Figure 12). This level of GLP-1 activation was 2-3 times higher than in our previous 
report (Kreisler et al., 2013) in which rats were not acclimated to consuming large meals.  After 
an overnight fast, rats in that study consumed only 5% BW of Ensure, and only ~30% of GLP-1 
neurons were activated (Kreisler et al., 2013).  In the present study, there were no differences in 
GLP-1 activation between rats consuming the entrained LD vs. the relatively more novel Ensure, 
regardless of dilution, suggesting that neither caloric density, novelty, nor flavor/palatability 
contributed significantly to feeding-induced GLP-1 neuronal activation. In a previous study, 
Vrang et al. (Vrang et al., 2003) reported that ~30-40% of GLP-2-positive neurons (i.e., which 
also are GLP-1-positive) were activated to express cFos in rats after inflation of a gastric balloon 
with 9 ml of saline, similar to the volume of Ensure voluntarily consumed by non-entrained rats 
in our previous study (Kreisler et al., 2013).  Thus, GLP-1 neuronal activation likely is due to 
stimulation of vagal mechanoreceptors that are sensitive to gastric distension. Indeed, 
correlational analyses in the present study indicated that cNTS GLP-1 neural activation was best 
predicted by the volume ingested, although we cannot rule out a possible additional contribution 
of intestinal nutrient exposure. 
 Despite eating more voluminous meals and emptying more calories into the intestines, 
RES-LD rats in the present study consumed ~19 ml (~7.5% BW) but displayed similar 
proportions of cNTS GLP-1 neuronal activation (~35%) as non-entrained, satiated rats in our 
previous study (~30% activation) (Kreisler et al., 2013), although rats in the previous study 
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consumed only ~9 ml (~5% BW) (Kreisler et al., 2013).  Considered together, these results 
suggest that the ability of a given amount of feeding-induced gastric distension to activate cNTS 
GLP-1 neurons varies based on experience consuming large meals. Specifically, meal 
entrainment may shift the intake-response curve to the right, such that greater amounts of food 
must be consumed in order to recruit the same proportions of GLP-1 neurons that are recruited 
by smaller amounts of food intake in non-entrained rats.  For a given volume of intake and 
gastric load, the reduced levels of GLP-1 activation in meal-entrained RES-LD rats (present 
study) vs. non-entrained rats in our previous study (Kreisler et al., 2013) may reflect 
physiological adjustments that permit larger meals to be consumed after entrainment (Woods, 
1991; Woods and Ramsay, 2000; Woods, 2002).  
 
3.4.2. Feeding-induced activation of GLP-1 neurons: MRF.  
 
Interestingly, although approximately half of all identified GLP-1 neurons in the caudal brainstem 
reside in the MRF, GLP-1 neurons within the cNTS were more sensitive to feeding-induced 
activation, consistent with a previous report (Gaykema et al., 2009).  These GLP-1 regional 
differences in cFos activation may be due to the fact that the cNTS receives direct vagal sensory 
input, including input arising from the GI tract, whereas sensory inputs to the MRF are indirect.  
The neural pathway(s) through which MRF GLP-1 neurons are recruited in rats after food intake 
is unknown. However, given that MRF neurons are recruited in an intake volume-dependent 
manner, similar to the progressive recruitment of cNTS GLP-1 neurons (Figure 12), the 
recruitment of MRF GLP-1 neurons could reflect relayed input from the cNTS (Aicher et al., 
1995; Bailey et al., 2006).  
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3.4.3. GLP-1 receptor blockade in meal-entrained rats.  
 
Our cFos data provide convincing evidence that GLP-1 neuronal activation closely reflects the 
amount consumed, in a manner that is modified by feeding experience (i.e., meal entrainment). 
Importantly, however, rats must consume at least 5-6% of their BW within a 1 h period 
(achieved either after fasting or by meal entrainment) before GLP-1 neural activation increases 
above baseline activation levels measured in rats with ad lib food access (Maniscalco and 
Rinaman, 2013). Therefore, insofar as cFos is an indicator of GLP-1 neural activation, our results 
indicate that GLP-1 neurons are relatively insensitive to sensory feedback signals generated by 
food intake, except when rats consume unusually large amounts during a relatively short period 
of time.  It follows that central blockade of GLP-1 receptor signaling should have little impact on 
food intake when endogenous GLP-1 signaling is relatively low, whereas an effect may be 
revealed when increased GLP-1 signaling accompanies the consumption of very large meals.  
Indeed, several studies have reported that i.c.v. Ex9 does not increase chow intake in ad lib-fed 
rats compared to intake by control rats treated with i.c.v. vehicle (Grill et al., 2004; Kanoski et 
al., 2011; Alhadeff et al., 2012; Zhao et al., 2012).   
The new Ex9 experiment in the present study used ad-lib fed rats that were trained to 
consume large volumes of palatable Ensure within a 2 h period. According to our hypothesis, 
this is the type of feeding scenario in which endogenous GLP-1 signaling may contribute to the 
termination of intake. If so, then central administration of Ex9 should block such signaling, 
promoting more excessive intake.  Cumulative 2 h intake in rats after i.c.v. Ex9 was compared 
both to baseline intake by the same rats in the absence of injection (i.e., within subjects) and also 
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to intake by a different group of rats after i.c.v. SAL treatment (i.e., between subjects). Ex9 
significantly increased 2 h cumulative intake within subjects, but not when compared to 2 h 
intake by rats treated with i.c.v. SAL.  Meal structure analyses revealed that, compared to the 
within-subjects effects of i.c.v. SAL treatment, Ex9 treatment increased the size and duration of 
the second (but not the first) meal consumed compared to baseline values in the same rats, and 
also increased the size of the second meal compared to values in SAL-treated rats. The 
differential effect of Ex9 vs. SAL treatment on second meal size was further enhanced by a 
significant decrease in second meal size in SAL-treated rats compared to their own baseline, 
likely reflecting a delayed hypophagic response to the mild stress of handling and i.c.v. injection 
that was not apparent during the first meal.   
The current analysis of cumulative intake and meal pattern data in rats under both non-
injected control conditions and after experimental treatment provides novel insights into the 
potential role of endogenous GLP-1 signaling in regulating food intake. To our knowledge, only 
one previous study has reported the effect of central Ex9 treatment on meal structure, with no 
reported effects on cumulative intake (Dossat et al., 2013).  In that study, ad lib-fed rats were 
trained to consume sweetened condensed milk or sucrose solution for 2 h each day, and then 
received either vehicle or Ex9 (in counterbalanced order) infused unilaterally into the NAcc 
before test meals.  Compared to intake after vehicle infusion, Ex9 increased meal size and 
duration and altered licking microstructure in a manner consistent with increased palatability, 
suggesting a site-specific role for GLP-1 signaling within the NAcc to reduce food palatability 
(Dossat et al., 2013).  However, meal structure data under non-injected baseline conditions were 
not reported, leaving open the possibility that intra-NAcc Ex9 also exerts at least some of its 
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effects by attenuating or counteracting the hypophagic effect of experimental treatment (i.e., 
central infusion).  
The effect of Ex9 to increase food intake/meal size in rats consuming 6-7 % of their BW 
(Experiment 2) is consistent with a substantial recruitment (40-50%) of GLP-1 neurons after rats 
consume similar volumes of liquid diet (Experiment 1). Thus, a behavioral effect of blocking 
endogenous GLP-1 signaling can be revealed when significant proportions of GLP-1 neurons are 
active. However, in considering the potential role of hindbrain GLP-1 neurons, it is important to 
remember that GLP-1 is not their sole signaling molecule.  In rats, GLP-1 neurons are 
glutamatergic (Zheng et al., 2014) and are likely to express a variety of additional neuropeptides, 
including inhibin , enkephalin, and/or somatostatin (Sawchenko et al., 1990). Thus, the 
relatively subtle effect of pharmacological GLP-1 receptor antagonism on cumulative food 
intake and meal size under certain experimental conditions does not preclude a potentially more 
important and/or more physiological role of GLP-1 neurons to control food intake that involves 
signaling by one or more co-expressed transmitter molecules. 
 
3.4.4. Perspectives  
 
We interpret our results as evidence that central GLP-1 signaling plays a role in satiation in rats 
consuming large, entrained meals of liquid diet. Compared to intake under baseline (i.e., non-
injected) conditions, i.c.v. administration of Ex9 increased cumulative intake volume, which was 
driven by an increase in second meal size in Ex9-treated rats compared to a decrease in vehicle-
treated rats.  Since i.c.v. saline vehicle reduced meal size and duration compared to intake under 
non-injected baseline conditions, at least part of the observed effect of Ex9 treatment is likely 
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attributable to drug-induced attenuation of the hypophagic effects of stress produced by the 
handling and i.c.v. injection procedures.  Indeed, central administration of Ex9 attenuates the 
hypophagic effects of other stressful treatments, including systemically administered LiCl 
(Rinaman, 1999b) or endotoxin (Langhans et al., 1991; Grill et al., 2004).  Although previous 
studies have reported that rats consume more food after i.c.v. Ex9 than after i.c.v. vehicle, these 
studies did not report baseline food intake under non-injected control conditions (Hayes et al., 
2009; Kanoski et al., 2011; Alhadeff et al., 2012; Zhao et al., 2012; Dossat et al., 2013).  
Therefore, while our results are consistent with those earlier reports, the current findings provide 
additional insight into the role of endogenous GLP-1 signaling in controlling food intake, i.e., by 
reducing meal size near the end of the feeding period when meal-entrained rats are consuming 
unusually large amounts of food, and also under experimental conditions that promote stress-
induced hypophagia.   
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4.0  GENERAL DISCUSSION 
4.1 SUMMARY AND INTERPRETATION 
Satiation is a sensory-driven process that begins when nutrients make contact with the mouth. 
While it is clear that the hindbrain is a hub in the central network involved in satiation, the neural 
phenotypes that participate in the integration of feeding-related sensory feedback and 
subsequently inhibit the motor patterns involved in feeding are unknown.  
 GLP-1 and PrRP-positive neurons in the caudal hindbrain are sensitive to a wide array of 
interoceptive stimuli, including those that reduce food intake. Furthermore, loss-of-function 
studies have supported a causal role for both systems in the regulation of energy balance. 
However, whether they are involved in the control of satiation is less clear. We proposed that 
these two signaling systems play a role in the control of physiological food intake. To challenge 
this hypothesis, my dissertation work was designed to address two overarching Aims:  
 
Aim 1: Demonstrate that food intake itself (in the absence of other experimental manipulations) 
activates DBH-positive, including PrRP-positive, and GLP-1-expressing neurons and assess the 
feeding-related sensory signals that recruit them.  
 
Aim 2: Assess the contribution of endogenous GLP-1 signaling to the control of food intake 
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In Chapter 3, we quantified cFos expression (a marker of neuronal activation) among 
phenotypically-identified DBH-positive (including both PrRP-positive and -negative subsets) 
and GLP-1 neurons in rats that undergoing their first experience with food deprivation following 
by refeeding on meals of differing sizes. Results demonstrated that: 
 
1. Both DBH-positive A2 and GLP-1 neurons effectively track food intake when fasted rats 
consumed satiating meals of varying sizes.  
 
2. Among DBH-positive neurons, those that express PrRP were more sensitive to meals of all 
sizes than those that do not express PrRP. 
 
3. Neuronal activation among PrRP-positive and GLP-1 neurons after large satiating meals (5 
%BW) was significantly more than the proportion of activation observed after non-satiating 
meals.  
 
Overall, these results support our overarching hypothesis that DBH-positive A2 and GLP-1-
positive neurons are sensitive to feeding-generated sensory signals. However, even the largest 
satiating meals consumed by these non-entrained rats activated only ~30%, and 45% of GLP-1 
and PrRP-positive neurons, respectively. Since the proportion of GLP-1 and PrRP-positive 
neurons expressing cFos was significantly and positively correlated with intake volume (Figures 
7 and 8), we hypothesized that rats consuming even larger volumes would display 
proportionately higher levels of GLP-1 and PrRP neural activation. To challenge this hypothesis, 
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quantification of cFos expression among the PrRP and GLP-1-positive neurons was extended to 
rats that were trained over 5 days to consume significantly larger volumes within a 1 h period 
(Chapter 4). Because activation of PrRP-negative neurons was significantly less than that of 
PrRP-positive neurons across all intake volumes in the previous experiment, quantification of 
cFos expression within the PrRP-negative subpopulation of A2 neurons (of which there are 
relatively few) was not performed in the following cFos experiment (Chapter 4). Results of cFos 
experiments in Chapter 4 demonstrated: 
 
1. Larger entrained meals produced a more robust proportion of activation among both GLP-1-
positive and PrRP-positive populations that similarly correlated with intake volume and caloric 
value (Figures 12 and 17).  
 
2. Entrained rats that consumed non-satiating meals, showed lower proportions GLP-1 and PrRP 
activation than would be expected based on the absolute volume of the those meals.  
 
3. Neuronal activation was not obviously affected by flavor nor novelty of the diet.  
 
4. Despite the fact that half of all hindbrain GLP-1 neurons reside in the MRF, this subpopulation 
was less sensitive to food intake that those in the cNTS. 
 
The progressive increase in GLP-1/ PrRP neuronal activation assessed in rats after intake 
of progressively larger volumes suggests that both populations of neurons participate in the 
process of satiation. However, it also is possible that these populations of neurons are simply 
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tracking gastric distension or some other feeding-related sensory signal, without actively 
participating in meal size control. To explore this, we used a commercially available specific 
GLP-1 receptor antagonist to block endogenous GLP-1 signaling and assessed subsequent meal-
related parameters and cumulative intake. Unfortunately there is no antagonist for GPR10 that 
would allow a comparable study to be performed for endogenous PrRP signaling. An alternative 
and novel approach is being developed in our laboratory that will enable loss-of-function studies 
to be performed for endogenous PrRP signaling specifically (Section 6.0).  
 
Results of pharmacological studies in Chapter 5 demonstrated that:  
 
1. Blockade of GLP-1 receptors increased cumulative intake volume compared to the amount 
consumed by the same animals in the absence of injection (baseline). 
 
2. Compared to baseline, saline injection decreased the size and duration of meals consumed 
during the latter half of the feeding period, whereas Ex9 treatment increased both of these 
parameters.  
 
3. Neither Ex9, nor SAL treatment had an effect on indices of satiety (intermeal interval and 
meal number), nor on the size/duration of meals consumed during the initial minutes of the 
feeding period. 
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Behavioral results of Chapter 4 supported a causal role for GLP-1 signaling in physiological 
satiation and not satiety during entrained meals. Such a role includes the ability to attenuate 
hypophagic responses to the mild stress associated with saline injection.  
4.2 DIFFERENTIAL ACTIVATION: PRRP V. GLP-1 
Assessing cFos expression in both PrRP-positive and GLP-1 neurons in the same animal allows 
for a direct comparison between the sensitivities of these two neuronal populations to meals of 
various sizes. Interpreted in and of itself, the pattern of GLP-1 activation in non-entrained rats 
(Figure 5) suggests that satiation is required for activation of GLP-1 neurons above the levels of 
fasted animals. However, when considering the progressive nature of GLP-1 neural activation 
responses that becomes apparent across a broader range of intakes (Figure 12), perhaps intake of 
2-3 %BW (consumed by 50% and 30% restricted groups, Figure 5) simply fails to reach a 
threshold required to begin recruiting GLP-1 neurons. However, meals of 3 %BW (30% 
restricted group) were sufficient to begin recruiting A2 (both PrRP-positive and PrRP-negative) 
neurons above fasting levels. In other words, differential sensitivities to feeding-generated 
sensory signals between A2 and GLP-1 neurons were particularly apparent when meal sizes were 
relatively small (less than ~ 4% BW).  
 This differential sensitivity between PrRP-positive and GLP-1 neurons was also apparent 
in rats that consumed restricted amounts of the expected LD (RES-LD). This group provided 
important information about the degree to which expectation or previous experience with very 
large meals influences neuronal responses. RES-LD rats ate non-satiating meals (60% of what 
they were used to eating), but the absolute volume of these meals (~7.5 %BW) and the amount 
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that emptied into the intestines (~7 kcal) were still larger than those of non-entrained Ensure 
meals consumed by non-entrained rats (Table 1). Interestingly, in RES-LD rats, the proportion of 
activation among both GLP-1 neurons and PrRP-positive was below the expected proportion 
based on the intake-response relationship among satiated rats (represented in Figures 12 and 17). 
The suppression was particularly apparent for PrRP-positive neurons (Appendix B, Figure 17). 
This result suggests that experience with cycles of deprivation followed by large meals (i.e., 
meal-entrainment) shifts the intake-response curve to the right, such that PrRP-positive and 
GLP-1 neurons are less sensitive to a gastric load of a given size.  
 The biological mechanism that is responsible for such entrainment-associated plasticity 
can only be speculated upon. One conceivable mechanism may be desensitization of vagal 
afferent neurons that carry feeding-generated sensory signals from the GI tract and synapse in the 
cNTS. The effect of meal-entrainment per se on the ability of vagal afferent to recruit brainstem 
neural circuits has never been directly explored. However, the sensitivity of vagal afferent 
neurons to metabolic signals is suppressed by diet-induced obesity (de Lartigue et al., 2011b; de 
Lartigue et al., 2011a; de Lartigue et al., 2012), suggesting that feeding experience may alter 
vagal function.  
   Another possibility may be the learned anticipatory hormonal (e.g., increased systemic 
ghrelin and insulin) or visceral motor (gastric relaxation) adjustments that have been previously 
described (Woods, 1991; Woods and Ramsay, 2000). From an adaptive perspective, these 
adjustments serve to permit larger meals during scenarios when food is scarce and must be 
consumed in large quantities in a confined period of time (replicated experimentally using meal-
entrainment). The relationship between such physiological adjustments and PrRP/GLP-1 neurons 
has not been specifically investigated. However, it is reasonable to hypothesize that these 
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adjustments involve the quieting of neural circuits with a presumed role in inhibiting food intake 
such as those that involve PrRP and/or GLP-1 neurons, in order to permit large meals. Viewed 
from this perspective, the suppression of feeding-induced neuronal activation amongst PrRP and 
GLP-1 neurons might itself be such an adjustment. 
 Although the proportions of both cNTS GLP-1 and PrRP-positive neurons that are 
activated by feeding closely reflect the amount consumed, the relationship between meal size and 
proportion of activation differs slightly between the two populations. In rats that consumed 
relatively smaller volumes (0-6 %BW), PrRP activation tended to be higher than that of GLP-1. 
In contrast, among rats that ate much larger amounts (~9-14 %BW), GLP-1 neuronal activation 
was usually higher than that of PrRP-positive neurons (Figure 15). Neither the anatomical nor 
functional relationship between PrRP and GLP-1-positive neurons has been explored. Also, cFos 
expression does not offer information about strength nor timing of synaptic input onto these 
neurons, nor firing patterns. Therefore, it is difficult to speculate about if or how these results 
reflect a certain degree of intercommunication between these populations.  
 However, a sensible interpretation of these differential sensitivities is that PrRP and GLP-
1-positive neurons might participate in parallel pathways that each transduces feeding-related 
information to central feeding networks in a slightly different way. Such a scenario might have 
adaptive significance in that, due to their slightly different intake-response patterns, together 
PrRP and GLP-1-postive neurons can provide more complete information about the meal.  
 Another interpretation of this inter-phenotype comparison is that the PrRP and GLP-1 
neurons that were activated by smaller meals represent a distinct subset from those that are 
activated by larger meals, and the relative size of these subsets differs between PrRP and GLP-1 
neurons. The extent to which subpopulations of PrRP or GLP-1 neurons have distinct projection 
  90 
targets or carry out distinct functional roles has not been adequately explored. However, some 
evidence exists for functionally diverse GLP-1 receptor populations (Kinzig et al., 2002; Kinzig 
et al., 2003) that may receive input from distinct subsets of cNTS neurons (Vrang et al., 2007).  
 Despite slight variations in the progression of activation, GLP-1 and PrRP-positive 
neurons both seem to reach a maximal proportion of activation, 60% for PrRP-positive neurons 
and 85% for GLP-1-positive neurons, at meals that were ~9 %BW (i.e., rats that consumed 14 
%BW showed no higher activation than those that consumed 9 %BW, Figure 15). Since further 
(> 14 %BW) intake is unlikely under voluntary conditions (Figure 9), this is likely to be the 
maximal proportion of each of these groups of neurons that are recruited during physiological 
feeding. Furthermore, if GLP-1 and PrRP-positive neurons do play a causal role in satiation, then 
presumably 85% or 60% of the population is sufficient to do so.  
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Figure 15. Differential activation of cNTS GLP-1 and PrRP-positive neurons 
Composite data depicting the relationship between meal size and percentage of GLP-1-positive 
and PrRP-positive neurons activated to express cFos in entrained and non-entrained rats (data 
compiled from Figures 7, 8, 12, and 16) under various experimental conditions. Each rat is 
represented by one blue and one red symbol that lie at the same horizontal coordinate. Feeding 
condition is not depicted for clarity. Open symbols represent RES-LD rats (Chapter 4) for which 
the indicated volume consumed was not satiating.  
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4.3 SATIATION VS. STRESS-INDUCED HYPOPHAGIA: IMPORTANCE OF 
INCLUDING NON-MANIPULATED CONTROLS 
Food intake is a normal daily process. However, food intake disturbs many tightly regulated 
physiological parameters and can itself be considered a challenge to homeostasis (Woods, 1991, 
2002). Therefore, a fine line exists between day-to-day satiation and stress-induced hypophagia 
and it is not unreasonable to view these processes as two behavioral phenomena that lie at 
different points along a continuum of homeostatic disruption.  Viewed from this perspective, 
results of experiments aimed at exploring the neural correlates of feeding behavior must be 
interpreted with consideration of the experimental, environmental, and physiological context 
surrounding ingestive event(s). 
 In the present study, vehicle treatment alone suppressed meal size and duration compared 
to baseline (non-injected) values. Recently published data from our laboratory demonstrated that 
an intraventricular saline injection alone activates ~60% of cNTS GLP-1 neurons in adlib-fed 
rats, significantly more than that observed in non-injected ad lib-fed controls (~20%, Maniscalco 
et al., 2015). Taken together, these results support the interpretation that Ex9-associated 
hyperphagia (compared to intake in vehicle-treated rats) observed in previous studies may be, at 
least partially, due to an attenuation of enhanced satiation mediated by endogenous GLP-1 
signaling after injection procedures. This interpretation is consistent with a role for endogenous 
GLP-1 signaling in stress-induced hypohagia rather than food intake per se (Appendix B). 
 In order to discriminate between a role for endogenous GLP-1 signaling in stress-induced 
hypophagia from that of normal satiation, we included intake data from the same rats before any 
injection procedures had occurred. By comparing these data to those after vehicle and Ex9 
treatment, a more complete assessment of the role for endogenous GLP-1 signaling in feeding is 
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possible. Until now, no existing studies utilizing Ex9 (except Maniscalco et al., 2015, in 
paragraph above) provide data from non-manipulated/injected controls. Therefore, further 
experiments that include a "no manipulation" experimental condition are needed in order to gain 
a better understanding of a role for GLP-1 signaling in normal satiation vs. stress-induced 
hypophagia.  
4.4 INTERPRETING DISCREPANCIES BETWEEN PUBLISHED EX9 STUDIES: 
CONSIDERING PRESENT RESULTS 
A substantial number of studies has measured cumulative food intake in rats after central 
administration of Ex9 in order to challenge a role for endogenous GLP-1 signaling in feeding. 
Some of these studies have reported increased food intake associated with Ex9 treatment, while 
others have reported similar intakes as vehicle injected controls. Together with results of cFos 
experiments conducted in our lab, closer examination of the different feeding paradigms used in 
these studies reveals a possible explanation for this discrepancy.   
 Ex9 treatment fails to have an effect in rats that are fasted overnight and are then allowed 
to consume a satiating test meal (Turton et al., 1996; Schick et al., 2003a; Hayes et al., 2009). It 
is presumed that rats in these studies have not been acclimated to fasting and refeeding (meal-
entrained) prior to experimental day, although this information is poorly reported. cFos results 
presented in Chapters 3 and 4 and (Maniscalco and Rinaman, 2013) show that an acute fast 
silences GLP-1 neurons. Even though consuming a satiating meal after such a fast increases 
GLP-1 neuronal activation, it only activates ~30% of GLP-1 neurons (Figure 10). Therefore, 
considering results of these cFos studies, it is not surprising that an overnight fasting followed by 
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refeeding fails to invoke sufficient GLP-1 signaling to see an effect of blocking it. A direct 
comparison between the ability of GLP-1 receptor blockade to enhance fasting- versus 
palatability-driven food intake has not been performed (see Section 6.0, #2, below).  
 On the other hand, several studies have reported Ex9-associated hyperphagia during 
experimental procedures that themselves might boost GLP-1 signaling. For example, when food 
access follows a large Ensure preload, distension of a gastric balloon (Hayes et al., 2009), or a 
saline injection (Turton et al., 1996; Hayes et al., 2009; Williams et al., 2009; Alhadeff et al., 
2012), Ex9 is able to further increase the amount consumed during the experimental food access 
period. All of these treatments have previously been shown to increase GLP-1 neuronal 
activation (Vrang et al., 2003; Kreisler et al., 2013; Maniscalco, in press). Therefore, presumably 
those treatments combined with the feeding that follows them, generates sufficient GLP-1 
signaling such that blocking it further increased food intake. Other studies have reported central 
Ex9-associated hyperphagia in ad lib-fed rats during consumption of a palatable test diet 
(Williams et al., 2009; Alhadeff et al., 2012). Although these studies report neither the amount of 
maintenance chow nor test diet that is typically consumed in the absence of experimental 
intervention, it is conceivable that unrestricted intake of a palatable diet in calorically-replete rats 
produces an unusual degree of gastric distension and thus further boosts GLP-1 signaling. 
Therefore, Ex9-associated hyperphagia is not surprising under the experimental conditions used 
in those studies.      
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5.0  FUTURE DIRECTIONS 
Results of studies comprising this dissertation support a role for GLP-1 and PrRP-positive 
neurons in the caudal NTS in transducing meal-related sensory information to central networks 
that control meal size. However, our current understanding of the neural circuitry that governs 
satiation is incomplete. Below is a non-comprehensive list of immediate research directions that 
address important questions generated from research herein, and that would expand our 
knowledge surrounding the neural control of satiation.  
 
1. In Chapter 4, we demonstrated that activation of central GLP-1 receptors by endogenous GLP-
1 contributes to meal size control. However, that study used a high dose of Ex9 that was 
administered into the lateral ventricle and presumably accessed all of the diffuse populations of 
GLP-1 receptors that have been identified (see Section 2.3). Therefore, we cannot attribute the 
observed hyperphagic effect of Ex9 to any given population in particular. Because the hindbrain 
is sufficient for satiation in decerebrate rats, GLP-1 receptors within the DVC or medullary 
nuclei are particularly good candidates for the downstream targets of the activated neurons 
observed in our studies. However, the possibility that our Ex9 treatment is disrupting an 
important modulatory role for GLP-1 signaling in forebrain, hypothalamic, or limbic structures 
cannot be discounted.   
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2. Pharmacological experiments in Chapter 4 were performed on rats that were ad lib fed (on 
chow) and had not lost BW over the course of the acclimation period. Therefore, Ensure intake 
in that study was driven by palatability and occurred in excess of homeostatic need. Because we 
did not perform a similar experiment using Ex9 in fasted rats, we cannot be sure that the 
observed effect of Ex9 does not extend to homeostatically-driven feeding. Several studies cited 
in Section 5.4 demonstrated a failure of Ex9 treatment to further increase cumulative food intake 
in fasted rats, suggesting that a role for endogenous GLP-1 signaling depends on feeding 
scenario. However, these studies reported neither the effects of such treatment on meal size 
versus meal frequency, nor included data from non-injected controls. Quantifying 2h fasting-
induced cumulative Ensure intake and meal patterns in Ex9 and vehicle-injected rats in our hands 
would provide an important and direct comparison to those of meal-entrained rats performed in 
Chapter 4. Together these results would create a more complete picture of the role that 
endogenous GLP-1 signaling plays in feeding. 
 
3. Results of cFos experiments presented in Chapter 3 and Appendix A support PrRP-positive 
neurons as another cell group within the cNTS that may play an important role in satiation. 
Unfortunately, no antagonist for GPR10 is currently available, which limits the ability to explore 
a causal role for endogenous PrRP signaling in satiation. However, our lab is currently 
developing a novel lentiviral-mediated short-hairpin RNA vector targeted to PrRP mRNA that 
will offer a minimally invasive technique by which to eliminate endogenous PrRP signaling 
specifically. By administering this vector into the PrRP-rich region of cNTS, the contribution of 
PrRP signaling originating from that region can be revealed. In vivo verification of this shRNA 
vector is ongoing in our laboratory.  
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APPENDIX A 
ACTIVATION OF PRRP-POSITIVE NEURONS IN CNTS IN MEAL ENTRAINED 
RATS 
Using the same immunolabeling, quantification, and data analysis procedures described in 
Sections 3.3.3 - 3.3.5, an adjacent tissue set was used to assess neuronal activation of PrRP-
positive neurons from the same meal-entrained rats in Chapter 4 (Experiment 1). Because 
analyses conducted in Chapter 3 revealed that PrRP-positive neurons are much more sensitive 
than PrRP-negative neurons to first-time deprivation-induced food intake (Figure 6), PrRP-
negative neurons were not included in this analysis in meal-entrained rats.  
In meal-entrained rats, as expected, there was no main effect of feeding condition on the 
number of PrRP-positive neurons counted within the cNTS [161.50 ± 41.67 neurons per rat; 
between-groups comparison F(4, 23) = 0.83, p > 0.05].  Also as expected, very few PrRP-
positive neurons were cFos-positive in NF rats, whereas cFos expression by PrRP neurons was 
increased in rats within all three fed groups (EN, diEN, and LD) that consumed satiating meals 
(Figure 16). ANOVA revealed a significant main effect of feeding condition on the proportion of 
PrRP-positive neurons expressing cFos within the cNTS [F(4, 23) =79.29, p < 0.001]. 
Interestingly, the proportion of activated PrRP-positive neurons in RES-LD rats (~9.5%) was 
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statistically similar to that of NF rats (5.9%, p > 0.05, Fig 16). Among the three groups that 
consumed unrestricted (i.e., satiating) amounts of EN, diEN, or LD, there were no between-
groups differences in activation of PrRP neurons (p > 0.05 for each between-group comparison; 
Figure 16). 
  





Figure 16. Activation of PrRP-positive neurons in meal-entrained rats 
Percentage of PrRP-positive neurons within the cNTS that express cFos immunoreactivity in the 
same meal-entrained rats used in Chapter 4 (Experiment 1). Different letters indicate significant 
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Figure 17 plots the grams of test diet consumed by individual rats (expressed as % BW) 
compared to cFos activation of cNTS PrRP-positive neurons across all feeding groups in Chapter 
4 (Experiment 1). For purposes of comparison, food intake (as % BW) and PrRP cFos activation 
data using non-entrained rats that consumed unrestricted amounts of Ensure (Figure 5) also are 
plotted in Figure 17.  In that earlier study, experimentally naïve rats that were fasted overnight 
and then re-fed for the first time consumed, on average, 4.7% BW of Ensure and displayed cFos 
activation of ~43.9% of cNTS PrRP neurons (Figure 5). Across both studies, activation of cNTS 
PrRP-positive neurons was positively (Pearson's R = 0.58) and significantly (p < 0.002) 
correlated with amount consumed (as % BW) across all 5 experimental fed groups (note that 
Entrained: NF group data are plotted in Figure 17 but are not included in correlational analysis). 
When only entrained (refed) rats in the present study are considered, activation of cNTS PrRP-
positive neurons was also positively (Pearson's R = 0.78) and significantly (p < 0.001) correlated 
with amount consumed (as %BW). cFos activation cNTS PrRP neurons in the present study also 
was positively and significantly correlated with the calculated value of calories emptied from the 
stomach (i.e., reaching the intestines; Table 2) by the time of perfusion (Pearson's R = 0.61, p = 
0.003, not shown). 
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Figure 17. Meal size and activation of PrRP-positive neurons in meal-entrained rats 
Relationship between amount consumed (as %BW) and cNTS PrRP neuronal activation in meal-
entrained rats consuming different diets (Chapter 4, Experiment 1). Each symbol represents one 
rat. Data from non-entrained, Ensure-fed rats (“Non-entrained: EN”) are included for comparison 
(as done in Figure 12). Data from Entrained: NF rats also are plotted for comparison, but the 











































Pearson’s R = 0.58 
p < .002 
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APPENDIX B 
SATIATION AND STRESS-INDUCED HYPOPHAGIA:  EXAMINING THE ROLE OF 
HINDBRAIN NEURONS EXPRESSING PROLACTIN-RELEASING PEPTIDE (PRRP) 
OR GLUCAGON-LIKE PEPTIDE 1 (GLP-1) 
ABSTRACT 
Neural circuits distributed within the brainstem, hypothalamus, and limbic forebrain interact to 
control food intake and energy balance under normal day-to-day conditions, and in response to 
stressful conditions under which homeostasis is threatened.  Experimental studies using rats and 
mice have generated a voluminous literature regarding the functional organization of circuits that 
inhibit food intake in response to satiety signals, and in response to stress.  Although the central 
neural bases of satiation and stress-induced hypophagia often are studied and discussed as if they 
were distinct, we propose that both behavioral states are generated, at least in part, by 
recruitment of two separate but intermingled groups of caudal hindbrain neurons. One group 
comprises a subpopulation of noradrenergic (NA) neurons within the caudal nucleus of the 
solitary tract (cNTS; A2 cell group) that is immunopositive for prolactin-releasing peptide 
(PrRP).  The second group comprises non-adrenergic neurons within the cNTS and nearby 
reticular formation that synthesize glucagon-like peptide 1 (GLP-1).  Axonal projections from 
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PrRP and GLP-1 neurons target distributed brainstem and forebrain regions that shape 
behavioral, autonomic, and endocrine responses to actual or anticipated homeostatic challenge, 
including the challenge of food intake.  Evidence reviewed in this article supports the view that 
hindbrain PrRP and GLP-1 neurons contribute importantly to satiation and stress-induced 
hypophagia by modulating the activity of caudal brainstem circuits that control food intake.  
Hindbrain PrRP and GLP-1 neurons also engage hypothalamic and limbic forebrain networks 
that drive parallel behavioral and endocrine functions related to food intake and homeostatic 
challenge, and modulate conditioned and motivational aspects of food intake. 
INTRODUCTION 
Factors that increase or decrease food intake do so by altering meal size, meal frequency, or both 
(Smith, 1998; Smith, 2000). Satiation – the natural process that ends a meal – is a brainstem-
mediated phenomenon in which food intake is terminated as a consequence of intake within that 
meal, thus influencing meal size.  In contrast, satiety is a post-ingestive state that precludes 
initiation of a meal, thereby influencing meal frequency. Satiation occurs in adult decerebrate 
rats in which the brainstem is surgically isolated from the hypothalamus and the rest of the 
forebrain (Grill and Norgren, 1978a; Seeley et al., 1994; Grill and Kaplan, 2002; Grill, 2010), 
and in neonatal rats with functionally immature forebrain-brainstem connections (Rinaman et al., 
1994). Satiation depends on peripherally-generated “satiety signals”, which decrease activity in 
brainstem circuits that maintain ingestive licking/chewing/swallowing behaviors, and/or increase 
activity in brainstem circuits that suppress these behaviors.  Although the brainstem is sufficient 
for satiation, the amount of food consumed before a meal is voluntarily terminated is powerfully 
modulated by neural signals from the forebrain and hormonal factors that increase or decrease 
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the behavioral potency of satiety signals (Grill and Hayes, 2012).  Some of these signals and 
factors act directly on the brainstem components of ingestive control circuits, while others act 
indirectly by engaging hypothalamic and limbic forebrain regions that influence the activity of 
brainstem ingestive control circuits via descending projections (Smith, 1998; Smith, 2000; Grill 
and Kaplan, 2002; Luckman and Lawrence, 2003; Smith, 2004; Grill and Hayes, 2009; Grill, 
2010).  Satiety signals and other feedback about the quality and quantity of food consumed are 
delivered to brainstem and forebrain regions that coordinate a host of feeding-related processes, 
including anticipatory and reflexive metabolic, endocrine, and autonomic adjustments, 
preference and avoidance learning, appetitive motivation, and behavioral state control (Grill and 
Kaplan, 2002; Luckman and Lawrence, 2003; Smith, 2004; Grill and Hayes, 2009; Grill, 2010; 
Rinaman, 2010; Berthoud et al., 2011; Grill and Hayes, 2012).   
Satiation and satiety are normal, everyday processes.  However, consuming a satiating 
meal can be stressful, especially if food intake occurs at an unusual (i.e., unpredicted) time, or if 
the meal is unusually large or calorically dense.  Food intake presents an immediate 
physiological challenge to homeostasis (Woods, 1991), and there is evidence that feeding 
activates the neuroendocrine hypothalamic-pituitary-adrenal (HPA) axis to increase circulating 
levels of glucocorticoids (i.e., cortisol in humans, corticosterone in rats and mice) (Shiraishi et 
al., 1984; Dallman et al., 2004).  The HPA axis is primarily involved in energy storage and 
mobilization under baseline conditions and in response to homeostatic challenge (Dallman et al., 
2004), and stressors are commonly defined as internal or external stimuli that increase HPA axis 
activity above baseline circadian-modulated levels.  Meals are fundamentally disruptive to 
homeostasis because they cause significant changes in a variety of important physiological 
parameters that are under constant surveillance and regulation, such as gastrointestinal 
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distension, liver temperature, osmotic pressure, and blood glucose (Woods, 1991; Woods and 
Ramsay, 2000).  Viewed from this perspective, it is reasonable to propose that there is a very fine 
line between central circuits that inhibit food intake during satiation and satiety, and those that 
inhibit intake during acute stress.  The idea that satiety signals and hypophagic stressors might 
recruit a common set of neurons and circuits is not new [e.g., see (Ritter et al., 1999; Seeley et 
al., 2000; Calvez et al., 2011)], but the putatively shared circuits whose recruitment results in 
decreased meal size and/or frequency remain to be identified.   
The present review discusses evidence that inhibition of food intake by satiety signals 
and by hypophagic stressors is mediated, at least in part, by recruitment of two phenotypically 
distinct but anatomically intermingled populations of hindbrain neurons.  The first population 
comprises noradrenergic (NA) neurons within the caudal nucleus of the solitary tract (cNTS; A2 
cell group), a majority of which express prolactin-releasing peptide (PrRP; Maruyama et al., 
2001).  PrRP was identified as an endogenous ligand for the human orphan G-protein-coupled 
receptor hGR3/GPR10, and earned its name because it induces prolactin secretion from anterior 
pituitary cells in vitro (Hinuma et al., 1998).  However, PrRP is absent from the external layer of 
the median eminence, and there is no evidence that endogenous PrRP plays any physiological 
role in prolactin release.  Instead, mRNA for PrRP receptor (hGR3/GPR10) is expressed in 
multiple brainstem and forebrain regions implicated in feeding, behavioral, and physiological 
responses to stress (Roland et al., 1999; Lawrence et al., 2000; Yamada et al., 2009).  PrRP 
mRNA is expressed exclusively by a subset of caudal medullary NA neurons, and by a small 
number of neurons in a ventral region of the caudal dorsomedial hypothalamic nucleus (Iijima et 
al., 1999; Roland et al., 1999; Onaka et al., 2010).  The second group of hindbrain neurons with a 
proposed role in both satiation and stress-induced hypophagia synthesize glucagon-like peptide 1 
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(GLP-1).  Despite the largely overlapping hindbrain distribution of PrRP and GLP-1 neurons, the 
latter are a completely distinct population of non-adrenergic neurons that expresses mRNA for 
preproglucagon (PPG), the protein precursor of GLP-1.  Within the brain, PPG mRNA 
expression is limited to the olfactory bulb, the cNTS, and the caudal medullary reticular 
formation (Larsen et al., 1997; Merchenthaler et al., 1999)1.  Since PPG-expressing neurons 
within the olfactory bulb are interneurons with very short axons, GLP-1 fibers and terminals 
throughout the rest of the CNS can be assumed to originate from hindbrain PPG-expressing 
neurons.  
Results from many published reports indicate that food intake in rats and mice is reduced 
after central infusions of PrRP, GLP-1, or their synthetic analogs (Tang-Christensen et al., 1996; 
Turton et al., 1996; Imeryuz et al., 1997; McMahon and Wellman, 1997; Asarian et al., 1998; 
McMahon and Wellman, 1998; Thiele et al., 1998; Lawrence et al., 2000; Kinzig et al., 2002; 
Lawrence et al., 2002; Schick et al., 2003b; Grabauskas et al., 2004; Lawrence et al., 2004; 
Bechtold and Luckman, 2006; Nakade et al., 2006b; Takayanagi et al., 2008; Holmes et al., 
2009; Takayanagi and Onaka, 2010; Hayes et al., 2011b; Alhadeff et al., 2012).  Such studies are 
important, and provide a strong foundation for the hypothesis that both neural populations drive 
hypophagia.  However, delivery of synthetic peptides or their analogs into the brain is a poor 
model for understanding whether stimulus-induced release of endogenous PrRP or GLP-1 
contributes to satiation or stress-induced hypophagia.  The present review focuses on results 
from a smaller number of studies providing evidence that satiety signals and acute stress inhibit 
                                                 
1 Amoeboid microglia also contain GLP-1 immunoreactive material, at least when activated in culture (Iwai T, Ito S, 
Tanimitsu K, Udagawa S, Oka J (2006) Glucagon-like peptide-1 inhibits LPS-induced IL-1beta production in 
cultured rat astrocytes. Neuroscience research 55:352-360.) suggesting that under certain pathological conditions 
activated microglia may release GLP-1 to access receptors in brain sites not normally targeted by the axons of 
hindbrain GLP-1 neurons. 
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food intake by recruiting endogenous PrRP and GLP-1 signaling pathways.  Before reviewing 
those data, we first review the anatomical location, neurochemical features, and circuit 
connections of hindbrain PrRP and GLP-1 neurons.  
 
ANATOMY OF THE DORSAL VAGAL COMPLEX AND ITS RESIDENT PRRP AND GLP-
1 NEURONS 
PrRP-immunopositive neurons and non-adrenergic GLP-1-immunopositive neurons are co-
distributed in the hindbrain near the medullary-spinal junction, within caudal levels of the NTS 
and the nearby medullary reticular formation (Figure 18). The cNTS is the “visceral” NTS, 
distinct from the more rostral “gustatory” NTS (Lundy-Jr. and Norgren, 2004). The cNTS is a 
key component of the dorsal vagal complex (DVC), which also includes the area postrema (AP) 
and dorsal motor nucleus of the vagus (DMV).  The DVC is remarkable for being perhaps the 
smallest circumscribed brain region whose destruction is incompatible with life.  It is a critical 
central node for autonomic and endocrine functions, relaying interoceptive visceral, hormonal, 
and somatic feedback from body to brain, tuning stress responsiveness, and regulating glucose 
homeostasis and other aspects of energy balance (Zagon et al., 1999; Rinaman, 2003; Berthoud 
et al., 2006; Rinaman, 2007; Grill and Hayes, 2009; Grill, 2010; Rinaman, 2010; Zhang et al., 
2010; Rinaman, 2011; Grill and Hayes, 2012).  The AP and a significant portion of the subjacent 
cNTS contain fenestrated capillaries, allowing blood-borne factors to affect neurons in this 
region (Yamamoto et al., 2003).  As recently reviewed (Grill and Hayes, 2009; Grill, 2010; 
Rinaman, 2010, 2011), AP neurons innervate the subjacent cNTS (Shapiro and Miselis, 1985; 
Kachidian and Pickel, 1993; Cunningham-Jr. et al., 1994), and cNTS neurons innervate other 
NTS neurons (including those located in the more rostral “taste” area) as well as gastrointestinal 
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and pancreatic vagal preganglionic parasympathetic motor neurons whose cell bodies occupy the 
DMV and whose dendrites ramify widely within the overlying cNTS (Shapiro and Miselis, 
1985).   
In addition to inputs from the AP, cNTS neurons receive sensory feedback from 
cardiovascular, respiratory, and alimentary systems (Kalia and Sullivan, 1982).  Visceral sensory 
inputs arrive predominantly via glutamatergic glossopharyngeal and vagal afferents whose 
central axons converge in the solitary tract before synapsing with the dendrites and somata of 
cNTS neurons, including GLP-1 and NA neurons, the latter of which undoubtedly includes the 
PrRP-positive majority subpopulation (Altschuler et al., 1989a; Rinaman et al., 1989; Spyer, 
1990; Bailey et al., 2006; Appleyard et al., 2007; Hisadome et al., 2010, 2011).  In the mouse in 
vitro slice preparation, glutamatergic visceral afferent signals produce tightly synced, large-
amplitude excitatory postsynaptic currents in NA and GLP-1 neurons within the cNTS, 
providing high-fidelity transmission of sensory nerve activity.  Other visceral and somatic 
sensory inputs are relayed to the cNTS from the spinal cord, trigeminal and related nuclei, and 
reticular formation (Menétrey, 1987; Arbab et al., 1988; Altschuler et al., 1989a; Menétrey and 
dePommery, 1991; deSousaBuck et al., 2001).  
Given the diversity of sensory signals they are positioned to receive, it is not surprising 
that GLP-1 and NA neurons, including PrRP neurons, respond to a broad array of interoceptive 
signals that can suppress food intake and also drive the HPA axis, including hormonal, thermal, 
osmotic, gastrointestinal, cardiovascular, respiratory, and inflammatory signals (Sawchenko and 
Swanson, 1981; Luckman, 1992; Rinaman and Levitt, 1993; Chan and Sawchenko, 1994; 
Rinaman et al., 1997; Callahan and Rinaman, 1998; Chan and Sawchenko, 1998; Dayas et al., 
2001; Hollis et al., 2004; Rinaman, 2004; Myers et al., 2005; Myers and Rinaman, 2005; Duale 
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et al., 2007; Gaykema et al., 2007; Bienkowski and Rinaman, 2008; Kasparov and 
Teschemacher, 2008; Takayanagi et al., 2008; Bonnet et al., 2009; Rinaman, 2010). In these 
cited studies and many others, stimulus-induced “activation” of NA, PrRP, and/or GLP-1 
neurons generally is characterized by double immunolabeling to localize nuclear cFos, the 
protein product of the immediate-early response gene, c-fos, together with cytoplasmic proteins 
identifying the chemical phenotype of activated neurons. As a binary index of neural activation, 
the presence or absence of cFos immunolabeling does not index the magnitude or duration of a 
neuron’s presynaptic inputs, or its resulting spike frequency. However, quantitative and regional 
analyses of neural cFos expression permit assessment of stimulus-induced activation across 
multiple populations of phenotypically-identified neurons under control and experimental 
conditions, making it an ideal approach for testing hypotheses regarding neural sensitivity and/or 
function.  The collective results of studies utilizing cFos indicate that NA, PrRP, and GLP-1 
neurons are consistently activated by stimuli that present actual or anticipated threats to bodily 
homeostasis (see below, Potential Role for PrRP and GLP-1 Neurons in Stress-Induced 
Hypophagia).  
PrRP and GLP-1 neurons participate in reciprocal connections with the medullary 
reticular formation, including the caudal ventrolateral medulla (cVLM), and other regions of the 
pons, diencephalon, and telencephalon that are implicated in food intake and body energy 
balance (Rinaman, 2010; Grill and Hayes, 2012).  Direct descending projections from the cortex, 
limbic forebrain, and hypothalamus to cNTS regions where PrRP and GLP-1 neurons reside 
provide a route through which emotional and cognitive events can modulate visceral and 
ingestive responses to diverse threats and opportunities to which the organism is exposed, 
including conditioned responses that are based on past experience (Sawchenko, 1983; Li et al., 
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1996; Li and Sawchenko, 1998; Woods and Ramsay, 2000; Dayas et al., 2001; Taché et al., 
2001; Buller et al., 2003b; Dayas et al., 2004; Price, 2005; Blevins and Baskin, 2010).  In turn, 
ascending projections from GLP-1 and NA neurons, including PrRP neurons, provide a route 
through which interoceptive feedback from the gastrointestinal tract and other organ systems can 
shape hypothalamic and limbic forebrain functions (Sawchenko, 1983; Loewy, 1990; Altschuler 
et al.; Onaka et al., 1995; Blessing, 1997; Rinaman, 2004; Onaka et al., 2010). 
 
Beyond the cNTS:  Many reports cited in the present review leave open the possibility 
that functions ascribed to central signaling by PrRP and/or GLP-1 neurons include signaling 
from neurons located not within the cNTS, but within the nearby medullary reticular formation. 
PrRP-positive neurons comprise a subset of the cVLM A1 noradrenergic cell group (Chen et al., 
1999), whereas GLP-1 neurons are scattered in regions somewhat dorsal and medial to the A1 
cell group (Vrang et al., 2007; Vrang and Grove, 2011).  However, limited evidence suggests 
that PrRP and GLP-1 neurons within the cNTS are functionally distinct from those located 
within the reticular formation.  For example, NA and GLP-1 neurons within the cNTS receive 
direct visceral sensory input (Hisadome et al., 2011), whereas those in the medullary reticular 
formation do not.  This may explain why A2 NA neurons within the cNTS are recruited to 
express cFos in meal-entrained rats that consume a large scheduled meal, whereas cVLM A1 
neurons are not activated (Rinaman et al., 1998). PrRP neurons within the cNTS also are 
activated in mice after a single cycle of 24-hr food deprivation followed by re-feeding, whereas 
PrRP neurons in the reticular formation are not (Takayanagi et al., 2008).  In addition, the ability 
of hypoglycemia to increase food intake apparently is mediated by NA neurons within the VLM, 
and not by neurons within the cNTS A2 cell group (Li et al., 2009). There is no published 
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evidence that GLP-1 neurons within the cNTS vs. reticular formation project to different brain 
areas or maintain separate functions, although this possibility should be examined.  It’s relevant 
to note here that non-NA projections from the cNTS to the cVLM (Hermes et al., 2006) allow 
visceral signals to recruit neurons of the A1 cell group (Tucker et al., 1987; Yamashita et al., 
1989; Kawano and Masuko, 1996; Bailey et al., 2006; Hermes et al., 2006), and the axons of 
many A1 neurons (including PrRP-positive neurons) join the ventral noradrenergic ascending 
bundle along with the axons of cNTS neurons that project rostrally from the hindbrain 
(Sawchenko and Swanson, 1981, 1982; Chan et al., 1995).  In the absence of specific evidence to 
discriminate between PrRP or GLP-1 neurons within the cNTS vs. medullary reticular formation, 
a conservative approach dictates that projections and functions ascribed to chemically distinct 


















Figure 18. Location of PrRP-positive and GLP-1-positive neurons in the rat hindbrain.   
A, Schematics illustrating the location of the cNTS (highlighted in blue), adapted from Swanson 
(2004).  The red line in the mid-sagittal brain schematic at upper left illustrates the rostrocaudal 
level of all coronal sections depicted in Figure 18 images.  B, In this image, dopamine beta 
hydroxylase (DbH) immunopositive NA neurons are green, while GLP-1-immunopositive 
neurons are red.  The two intermingled populations are distinct, with no colocalization of 
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immunolabeling.  C, GLP-1 immunoperoxidase-labeled neurons. D, DbH immunoperoxidase-
positive NA neurons of the A2 cell group.  E, In this image, all PrRP-positive neurons are 
double-labeled for DbH, rendering them yellow/orange (NA/PrRP neurons).  Some intermingled 
NA neurons (green) are PrRP-negative.  cc, central canal. 
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Other neurochemical features of PrRP and GLP-1 neurons:  PrRP neurons are 
phenotypically distinguished by mRNA expression and positive immunolabeling for PrRP as 
well as tyrosine hydroxylase (TH), the rate-limiting enzyme for dopamine synthesis, together 
with dopamine beta hydroxylase (DbH), the enzyme that converts dopamine to norepinephrine 
(NE) (Armstrong et al., 1982) (see Figure 18 for colocalization of PrRP and DbH 
immunolabeling within the cNTS).  A1 and A2 neurons do not express phenylethanolamine N-
methyltransferase, the enzyme that converts NE to epinephrine and identifies adrenergic neurons 
of the C1, C2, and C3 cell groups (Dahlström and Fuxe, 1964), which do not express PrRP 
(Morales et al., 2000).  When considering the functional role of PrRP neurons and their axonal 
projections, it’s important to keep in mind that these neurons release additional signaling 
molecules from their axon terminals and varicosities.  In rats, at least 80% of A2 neurons express 
mRNA for a homolog of the vesicular glutamate transporter-2 (Stornetta et al., 2002), suggesting 
that the majority (perhaps all) of PrRP neurons release glutamate along with NE and PrRP from 
their axon terminals. In addition, subpopulations of catecholaminergic NTS neurons are 
immunopositive for neuropeptide Y (Sawchenko et al., 1985; Everitt and Hökfelt, 1989), 
nesfatin-1 (Bonnet et al., 2009), dynorphin (Ceccatelli et al., 1992), neurotensin (Riche et al., 
1990), and/or pituitary adenylate cyclase-activating polypeptide (Das et al., 2007).  The extent to 
which cNTS PrRP neurons co-express these additional signaling molecules remains unclear.   
After posttranslational processing by the prohormone convertases PC1/3 and PC2, PPG-
expressing neurons generate GLP-1 and several additional peptides for which GLP-1 neurons are 
immunopositive, including GLP-2, glicentin, intervening peptide-2, and oxyntomodulin (Schafer 
et al., 1993; Baggio and Drucker, 2007; Vrang and Larsen, 2010). Indirect evidence suggests that 
beyond PPG-encoded peptides, GLP-1 neurons also are immunopositive for met-enkephalin, 
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somatostatin, and inhibin- (Sawchenko, 1988; Sawchenko et al., 1990; Sawchenko and Pfeiffer, 
1995).  Apparently, none of these signaling molecules are expressed by cNTS PrRP neurons 
(because none are expressed by NA neurons), and none of the neuropeptides that potentially are 
co-expressed by PrRP neurons (see previous section) have been localized to GLP-1 neurons.  
Another notable difference exists between PrRP and GLP-1 neurons in their expression of leptin 
receptors (Hay-Schmidt et al., 2001).  Evidence for direct neuronal sensitivity to leptin has only 
been presented by one study, in which leptin directly depolarized identified GLP-1 neurons in 
brainstem slice preparations from transgenic mice (Hisadome et al., 2010).  In mice, leptin 
receptor mRNA is expressed by GLP-1 neurons but not by NA or PrRP-positive cNTS neurons 
(Garfield et al., 2012).  Conversely, in rats, NA (and PrRP) neurons express leptin receptor 
immunolabeling (Ellacott et al., 2002) and exhibit pSTAT3 induction after ip leptin 
administration (Huo et al., 2008), evidence for direct leptin sensitivity.  Rat GLP-1 neurons do 
not exhibit pSTAT3 induction after ip leptin (Huo et al., 2008), but it is not known whether rat 
GLP-1 neurons express leptin receptors. Thus, not only do PrRP and GLP-1 neurons appear to 
display differential leptin sensitivity, their sensitivity appears to be reversed between rats and 
mice.   
 
Brainstem and forebrain targets of PrRP and GLP-1 neurons:  PrRP and GLP-1 neurons 
are well-positioned to participate in vago-vagal reflexes that modulate gastrointestinal motility, 
pancreatic hormone release, and other digestive-related autonomic processes associated with 
satiation and stress-induced hypophagia.  GLP-1 and NA neurons, including PrRP neurons, 
project locally within the DVC and medullary reticular formation, and also to the spinal cord, 
comprising a subset of pre-autonomic hindbrain neurons implicated in autonomic control of 
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cardiovascular and digestive functions (Fukuda et al., 1987; Rogers et al., 2003; Martinez-Peña-
y-Valenzuela et al., 2004; Hermann et al., 2005; Travagli et al., 2006; Duale et al., 2007; Pearson 
et al., 2007; Llewellyn-Smith et al., 2011; Llewellyn-Smith et al., 2013).  Pancreatic and gastric 
vagal motor neurons express GLP-1R in rats (Wan et al., 2007; Holmes et al., 2009), and the 
ability of restraint stress to impact intestinal motility is blocked by central GLP-1R antagonism 
(Gulpinar et al., 2000).  Intra-DVC or 4th ventricular microinjection of PrRP or GLP-1 has 
pronounced effects on vagally-mediated gastric motility, and results from in vitro slice 
preparations suggest that PrRP regulates gastric motor function by modulating the efficacy of 
excitatory synaptic inputs to vagal motor neurons (Grabauskas et al., 2004).   
Axons and varicosities arising from PrRP and GLP-1 neurons also occupy regions of the 
spinal cord and pontine and medullary reticular formation that contain the pattern generators, 
pre-motor neurons, and motor neurons that control ingestive consummatory behaviors (i.e., 
licking/chewing/swallowing) (Norgren, 1978; Travers et al., 1997; Chen et al., 2001; Yano et al., 
2001; Grill and Kaplan, 2002; Travers and Rinaman, 2002; Chen and Travers, 2003; Grill, 
2010).  Thus, PrRP and/or GLP-1 neurons may control the behavioral output of ingestive circuits 
to thereby induce or shape satiation and stress-induced hypophagia (Figure 19).  Additional 
support comes from a transneuronal viral tracing study demonstrating that cNTS neurons provide 
synaptic input to oral pre-motor or motor neurons (Travers and Rinaman, 2002) with 
demonstrated importance for feeding control (Travers et al., 1997; Travers et al., 2010).  It 
remains to be determined whether PrRP and GLP-1 neurons are among the cNTS neurons that 
are synaptically linked to ingestive pattern generators and oral motor output circuits. 
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Dual-labeling retrograde tracing and fiber lesion studies indicate that NA neurons, 
including PrRP-positive neurons, and GLP-1 neurons also project to multiple higher brain 
regions implicated in behavioral and physiological components of food intake (Morales et al., 
2000; Renner et al., 2010; Rinaman, 2010, 2011; Renner et al., 2012).  PrRP- and GLP-1-
positive fibers have been localized to every medullary, pontine, mesencephalic, diencephalic, 
and limbic forebrain region that receives axonal input from the cNTS.  Subsets of A2 neurons, 
presumably including PrRP neurons, have axon collaterals that innervate two or more forebrain 
targets (Petrov et al., 1993; Banihashemi and Rinaman, 2006; Schiltz and Sawchenko, 2007; 
Bienkowski and Rinaman, 2008). One study reported that 11-20% of hindbrain GLP-1 neurons 
were retrogradely labeled after either PVN or DMH tracer injections, but relatively few (i.e., 15-
25%) of the tracer-labeled neurons projected to both hypothalamic nuclei (Vrang et al., 2007).  
On the other hand, 30-40% of all hindbrain GLP-1 neurons reportedly innervate the midbrain 
ventral tegmental area (VTA) or the ventral striatal nucleus accumbens (NAcc) (Alhadeff et al., 
2012), indicating that subsets of GLP-1 neurons probably send collateralized axonal projections 
to multiple brain regions.   Some individual A2 neurons have axons that collateralize to regions 
of the medullary reticular formation as well as to the limbic forebrain (Reyes and Bockstaele, 
2006).  Interestingly, however, individual A2 neurons appear to target either the pons or the 
VLM, but not both (Hermes et al., 2006), suggesting a higher degree of anatomical specificity 
for projections within the brainstem vs. projections to the hypothalamus and limbic forebrain.   
Regarding hypothalamic projections, of particular relevance to the present review is 
evidence that PrRP and GLP-1 axonal projections target the medial parvocellular subregion of 
the paraventricular nucleus of the hypothalamus (mpPVN), where they form synaptic contacts 
with corticotropin releasing hormone (CRH)-positive neurons (Liposits et al., 1986; Matsumoto 
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et al., 2000; Sarkar et al., 2003) at the apex of the HPA axis.  CRH is the principal and obligate 
hypophysiotropic peptide driving the HPA axis under basal conditions and in response to 
homeostatic challenge (Plotsky et al., 1989; Watts, 1996), and PrRP acts synergistically with NE 
to activate CRH neurons and the HPA axis (Maruyama et al., 2001; Seal et al., 2002; Uchida et 
al., 2010).  Lesions that decrease NA input to the mpPVN markedly attenuate CRH neuronal 
cFos activation responses to interoceptive signals (Li et al., 1996; Fraley and Ritter, 2003; 
Rinaman, 2003; Ritter et al., 2003; Rinaman, 2007; Schiltz and Sawchenko, 2007; Bienkowski 
and Rinaman, 2008).  Central administration of PrRP or GLP-1 activates cFos in the large 
majority of CRH-positive mpPVN neurons, and also increases plasma levels of corticosterone 
(Turton et al., 1996; Rowland et al., 1997; Kinzig et al., 2003; Mera et al., 2006). Although these 
cFos results by themselves do not prove that CRH neurons are activated directly by PrRP, NE, or 
GLP-1 receptor-mediated stimulation, bath application of GLP-1 to mouse hypothalamic slices 
increase spike frequency in a majority of PVN neurons (Acuna-Goycolea et al., 2004).  Evidence 
for a mediating role of endogenously released GLP-1 comes from experiments demonstrating 
that the ability of stress to activate the HPA axis is markedly attenuated in rats after third 
ventricular administration of a GLP-1 receptor (GLP-1R) antagonist (Kinzig et al., 2003).  
Interestingly, however, GLP-1R -/- mice display paradoxically increased plasma corticosterone 
levels in responses to acute stress (MacLusky et al., 2000), suggesting that one role of 
endogenous GLP-1R signaling (at least in mice) may be to restrain or limit stress hormone 
secretion.  This is consistent with the idea that GLP-1 signaling may serve a protective role to 
limit stress responses in the face of threat, e.g., to limit fever after immune challenge (Rinaman, 
2000), and perhaps to guard against the overconsumption of unanticipated and/or excessively 
large meals. 
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As discussed in the Introduction (section 1.0), the HPA axis is activated by real or perceived 
homeostatic threats, including ad libitum (ad lib) or deprivation-induced food intake.  By virtue 
of their synaptic inputs to CRH neurons, we hypothesize that PrRP and GLP-1 neurons may 
drive HPA axis responses to food intake, because PrRP and GLP-1 neurons drive HPA axis 
responses to some (but not all) experimental stressors (Rinaman, 2010, 2011).2  In the mature, 
intact brain, PrRP and GLP-1 neurons innervate not only brainstem but also hypothalamic and 
limbic forebrain regions that control parallel autonomic, endocrine, and behavioral aspects of 
satiation and stress-induced hypophagia.  In this regard, we view HPA axis activation as 
occurring in parallel with, but relatively independent from, the brainstem-mediated behavioral 
processes of satiation and hypophagia, which do not depend on neural connections between the 
brainstem and forebrain (Grill and Norgren, 1978a; Hall and Bryan, 1980; Hall and Swithers-
Mulvey, 1992; Rinaman et al., 1994; Seeley et al., 1994; Grill and Kaplan, 2002). The following 
sections review evidence that PrRP and GLP-1 signaling pathways participate in satiation, and 
the final section (Potential Role of PrRP and GLP-1 Neurons in Stress-induced Hypophagia) 
reviews evidence that similar signaling pathways contribute to stress-induced hypophagia. 
                                                 
2 HPA axis recruitment by PrRP and GLP-1 signaling pathways is discussed further in section 
4.0 of this review.   
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Figure 19. Summary schematic of our working hypothesis.   
Cognitive stressors originate from conditioned and unconditioned cues that are processed 
through the cortex, hippocampus, and/or limbic forebrain before engaging the HPA axis and 
cNTS.  Visceral stressors typically are unconditioned stimuli that first engage cNTS neurons 
(including PrRP and GLP-1 neurons) that innervate hypothalamic and limbic forebrain targets to 
recruit the HPA axis.  Neurons within the cNTS engage brainstem targets to organize ingestive 
motor output.  
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POTENTIAL ROLE OF PRRP AND GLP-1 NEURONS IN SATIATION 
To examine whether endogenous NA and/or GLP-1 signaling pathways contribute to normal 
feeding-induced satiation, a few studies have examined whether phenotypically identified NA or 
GLP-1 neurons within the cNTS, the former presumably including PrRP-positive neurons, are 
differentially activated to express cFos in rats that have recently consumed a large satiating meal, 
a smaller non-satiating meal, or no meal (Rinaman et al., 1998; Rinaman, 1999a; Gaykema et al., 
2009; Kreisler and Rinaman, 2012).  In other studies, pharmacological and genetic manipulations 
have been used to investigate whether rats or mice consume more food when the central 
receptor-mediated effects of endogenously released PrRP or GLP-1 are attenuated or eliminated 
[e.g., (Schick et al., 2003a; Takayanagi et al., 2008; Hayes et al., 2009; Barrera et al., 2011; 
Dossat et al., 2011; Alhadeff et al., 2012; Dickson et al., 2012)].  These general experimental 
approaches are among the best currently available for testing hypotheses about the endogenous 
central neural underpinnings of satiation and/or stress-induced hypophagia.  However, the results 
of such studies must be interpreted within their own unique experimental context, with particular 
attention paid to the feeding paradigm utilized and any requisite surgical manipulations and 
handling.   
 
Feeding-induced activation of PrRP and GLP-1 neurons:  In the absence of experimental 
manipulations, the cNTS displays very low levels of neuronal cFos expression in ad lib-fed 
(presumably satiated) adult rats that are killed during the first few hours of the light cycle.  Under 
such conditions, identified PrRP and NA neurons rarely express cFos in rats or mice (Shirohzu et 
al., 2008; Maniscalco et al., 2012a). Conversely, in alternate tissue sections from the same 
satiated rats, approximately 20% of identified GLP-1 neurons express cFos (Maniscalco et al., 
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2012a).  This moderate level of “baseline” GLP-1 activation is markedly reduced (i.e., from 
~20% to less than 4%) if rats are not allowed to eat for 16-24 hours before sacrifice (Kreisler and 
Rinaman, 2012; Maniscalco et al., 2012a).  Insofar as neuronal sensitivity is revealed by cFos 
labeling, these findings suggest that GLP-1 neurons are more sensitive than PrRP neurons to 
signals associated with post-prandial satiety in non-manipulated, ad lib-fed rats.   Post-prandial 
satiety signals, which may be distinct from signals that promote satiation within a meal, could 
include gastrointestinal/colonic distension, post-absorptive nutrient levels, and circulating factors 
such as GLP-1, leptin, insulin, or ghrelin, for which plasma levels differ significantly in satiated 
rats and mice compared to levels measured after food deprivation (Mizuno et al., 1999; Kmiec et 
al., 2005; Kmiec et al., 2006; Johansson et al., 2008). 
Under ad lib feeding conditions, laboratory rats typically maintain their body weight by 
consuming a large number (e.g., 10-15) of small meals each day, with ~80% of daily food intake 
occurring nocturnally, and the largest meals predictably consumed near the beginning and end of 
the dark phase of the photoperiod (Kissileff, 1970; Strubbe et al., 1986; Collier and Johnson, 
1990; Woods, 2002).  With few exceptions, published studies examining central cFos responses 
to feeding-induced signals use paradigms in which rats are acclimated over the course of several 
days or longer to a repeating schedule of food deprivation followed by re-feeding, in order to 
train them to voluntarily consume a meal that is unusually large compared to the typical size of 
an ad lib meal.  Over the course of a week or two, through a Pavlovian process of classical 
conditioning, the animal learns to anticipate how much food can be safely consumed during the 
re-feeding period (including the approximate caloric and macronutrient composition of the meal) 
as it learns to initiate appropriately-timed cephalic phase responses (e.g., increased insulin 
release, gastric relaxation, digestive enzyme secretion) to ensure that larger meals can be safely 
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consumed (Woods and Ramsay, 2000; Woods, 2002).  As pointed out in the Introduction (1.0), 
these anticipatory adjustments are vitally important, because the energetic benefits of eating are 
counterbalanced by the energetic cost of homeostatic challenge (Woods, 1991, 2002).  
Progressive meal-induced recruitment of visceral sensory “satiety” signals from the 
gastrointestinal tract to the hindbrain serve to constrain meal size during both ad lib and 
scheduled meal feeding, thereby limiting the stressful effects of food intake (Smith, 1998; 
Woods, 2002) through a process termed “meal tolerance” (Woods and Ramsay, 2000).   
When experimentally naïve rats are food deprived for 24 hr and then re-fed for the very 
first time on chow or palatable liquid diet early in the dark cycle, both NA and GLP-1 neuronal 
populations are activated to express cFos in direct proportion to the gastric distension produced 
by the meal (Kreisler and Rinaman, 2012), suggesting that both PrRP and GLP-1 neurons might 
contribute to meal-induced satiation in this experimental context.  Although the PrRP-positive 
subpopulation of NA neurons has not yet been examined for feeding-induced activation in rats, 
first-time re-feeding after a 24-hr fast does activate PrRP neurons in experimentally naïve mice 
(Takayanagi et al., 2008).  After several days of acclimation to a repeating schedule of overnight 
food deprivation followed by a predictable solid or liquid morning meal, rats voluntarily 
consume an even larger amount, and cNTS NA neurons, presumably including PrRP neurons, 
still are acutely activated in proportion to the gastric distension produced by the meal (Rinaman 
et al., 1998).  However, in the same rats, GLP-1 neurons are not activated (Rinaman, 1999a).  
Considered together, these findings suggest that NA and PrRP neurons contribute to meal-
induced satiation in both experimental contexts, whereas GLP-1 neurons adapt or acclimate to 
signals such as gastric distension, elevated blood glucose, or insulin secretion that are predictably 
generated by a large scheduled meal.  Indeed, the hypothesized acclimation of GLP-1 neurons 
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during scheduled meal feeding may be part of the Pavlovian process through which meal-
entrained rats learn to tolerate the stress of consuming larger meals.  In other words, a lack of 
GLP-1 neuronal recruitment may represent attenuation or removal of a “brake” on intake that 
would otherwise constrain meal size via engagement of GLP-1 receptors in the caudal brainstem, 
which reduces meal size (Hayes et al., 2008; Grill and Hayes, 2009; Hayes et al., 2009).  If so, 
then GLP-1 neural recruitment by food intake in rats that are food-deprived and then re-fed for 
the very first time may help explain why these rats consume a smaller meal compared to 
acclimated, meal-entrained rats.    
 
 Increased food intake after pharmacological blockade of endogenous PrRP and GLP-1 
signaling:  There currently are no available pharmacological tools with which to antagonize 
PrRP (hGR3/GPR10) receptors.  However, central administration of a monoclonal anti-PrRP 
antibody in rats was reported to increase meal size but not meal frequency, and to increase total 
food intake compared to the effects of a control antibody (Takayanagi et al., 2008).  These 
results support the hypothesis that endogenous PrRP signaling participates in meal-induced 
satiation, but it is unclear where in the brain the proposed signaling occurs or whether satiation 
can be attributed to hindbrain populations of PrRP neurons as opposed to those located in the 
dorsomedial hypothalamus.  It also is unclear whether meal size and total food intake measured 
in control rats after central injection of control antibody was reduced compared to similar 
measures in non-manipulated rats.  The importance of including non-manipulated controls is 
discussed further, below (see the end of section 3.2).  
Central GLP-1 signaling can be effectively disrupted by central administration of 
Exendin-9 (Ex-9), a specific GLP-1R antagonist.  Daily intraventricular administration of Ex-9 
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produces daily increases in food intake compared to intake by rats after vehicle administration 
(Barrera et al., 2011), although it’s not clear whether this effect depends on increased meal size 
(supporting a role in satiation), meal frequency (supporting a role in appetite/motivation), or 
both.   Parenchymal administration of Ex-9 into subregions of the mesolimbic reward system, 
i.e., the VTA or NAcc, increases short-term intake of chow, palatable high fat diet, and sucrose 
in rats (Dossat et al., 2011; Alhadeff et al., 2012; Dickson et al., 2012), suggesting that GLP-1 
signaling in these regions may normally act to suppress reward-driven intake.  Ex-9 targeted to 
the lateral hypothalamus enhances short-term food intake in ad lib-fed rats, but has no effect on 
food intake in 24-hr food deprived rats (Schick et al., 2003b), perhaps because intake in deprived 
rats already is quite high.  Conversely, Ex-9 injections targeted to the 4th ventricle or cNTS 
increase the amount of food consumed by rats after gastric distension, but not after intestinal 
nutrient infusions (Hayes et al., 2009).  Results from these studies support the view that 
endogenous GLP-1 signaling suppresses or limits food intake across a variety of experimental 
conditions, and the cNTS/hindbrain may be an especially sensitive site of action for this effect 
(Grill and Hayes, 2012).  Indeed, the hypothalamus and forebrain are not required for the ability 
of GLP-1 signaling to suppress gastric emptying and food intake in rats, as these responses are 
preserved in chronic supracollicular decerebrate rats (Hayes et al., 2008). 
 A potential interpretational problem in the studies cited above is the typical comparison 
of data from surgically-manipulated and/or drug-infused rats with data from control rats 
subjected to sham surgery and/or infused with vehicle.  While these are appropriate experimental 
controls, they are incomplete.  The manipulations employed in these studies are often complex, 
requiring one or more surgical sessions (e.g., to equip animals with chronic brain cannulas or 
intravenous catheters), and acute handling for central or systemic drug injection.  Such 
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manipulations are themselves likely to promote some degree of stress-induced hypophagia, such 
that “baseline” food intake measured in animals after central or systemic vehicle treatment may 
be less than intake that would be observed under non-manipulated conditions. Accordingly, the 
ability of centrally administered Ex-9 or anti-PrRP antibody to increase food intake could be 
interpreted as evidence that central GLP-1 or PrRP signaling attenuates stress-induced 
hypophagia.  Some experiments have attempted to address this issue by pre-exposing animals to 
experimental handling and drug infusion conditions in order to habituate them to the potentially 
stressful aspects of those conditions.  However, results in “habituated” animals rarely are 
compared to results obtained in non-manipulated animals, making it unclear whether or how the 
habituation procedure affected results.  It will be important for future studies to include 
additional comparative data from non-manipulated controls. 
 
 Increased food intake after genetic manipulation of PrRP and GLP-1 signaling: To 
better understand the role of endogenous GLP-1 signaling in satiation and long-term energy 
balance, one research group used a knockdown strategy in which short hairpin RNA was 
microinjected into the cNTS of adult rats to suppress endogenous PPG expression; this produced 
a significant and long-lasting increase in daily food intake and body weight compared to control 
rats (Barrera et al., 2011).  However, it might be argued that the brainstem surgery itself in that 
study had a marked and long-lasting effect to reduce food intake and body weight growth, and 
that knockdown of PPG expression merely attenuated the deleterious effects of surgery.   
Evidence challenging a physiological role for GLP-1 signaling in daily food intake control 
comes from research using GLP-1R -/- mice, which are lean and consume a similar number of 
daily calories compared to wild-type mice (Scrocchi et al., 1996).  In considering this apparent 
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discrepancy in results, a recent review (Vrang and Larsen, 2010) pointed out that GLP-1R -/- 
mice display an apparent disturbance in satiation, such that termination of food intake is delayed 
early in the dark period, thereby prolonging the initial nocturnal meal.  This is followed by a later 
suppression of intake to achieve caloric compensation [see Figure 5A in (Scrocchi et al., 2000)].   
GPR10 (PrRP receptor)-deficient mice display hyperphagia under ad lib feeding 
conditions, but not in a one-time 16 hr fasting/re-feeding protocol (Gu et al., 2004).  In addition, 
GPR10 is required for the ability of exogenously administered PrRP and CCK to inhibit food 
intake in mice (Bechtold and Luckman, 2006). PrRP-deficient mice also display hyperphagia and 
increased body weight when maintained either on normal chow or on a high-fat diet (Mochiduki 
et al., 2010). In another study, PrRP-deficient mice displayed increased meal size (but not 
frequency) under ad lib feeding conditions, increased intake after deprivation, and reduced 
responsiveness to the feeding-suppressive effects of exogenous cholecystokinin octapeptide 
(CCK) and leptin (Takayanagi et al., 2008), which endogenously function as satiety signals.  
Interestingly, a polymorphism in the GPR10 gene that abolishes binding of PrRP in brain slices 
does not affect the ability of exogenously administered PrRP to suppress food intake in rats 
(Ellacott et al., 2005), suggesting that the hypophagic effects of the endogenous peptide could 
also be mediated through another, as yet unidentified, receptor signaling mechanism in rats.  
Additional studies will be required to examine this issue.  However, there is compelling evidence 
that a natural mutation of the GPR10 receptor (in addition to mutation of CCK-1 receptors) in the 
Otsuka Long-Evans Tokushima Fatty (OLETF) rat underlies its obese phenotype, and OLETF 
rats are insensitive to the hypophagic effects of exogenously administered PrRP (Watanabe et al., 
2005).  
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POTENTIAL ROLE OF PRRP AND GLP-1 NEURONS IN STRESS-INDUCED 
HYPOPHAGIA 
To the extent that it has been examined, GLP-1, PrRP, and NA neurons within the cNTS express 
cFos in every experimental situation in which food intake is acutely inhibited and the HPA axis 
is activated (Bouton and Bolles, 1980; Callahan and Rinaman, 1998; Rinaman et al., 1998; 
Rinaman, 1999a, 2003; Vrang et al., 2003; Zhu and Onaka, 2003; Onaka, 2004; Rinaman, 2004; 
Mera et al., 2006; Gaykema et al., 2007; Gaykema et al., 2008; Bonnet et al., 2009; Gaykema et 
al., 2009; Jelsing et al., 2009; Uchoa et al., 2009; Rinaman, 2010).  As if to emphasize the close 
relationship between brainstem neural recruitment and endocrine responses to hypophagic 
stressors, systemically administered amylin reduces meal size but does not activate NA or GLP-1 
neurons, and amylin does not activate the HPA axis (meaning it is not stressful) (Potes and Lutz, 
2010).  Acute stressors that activate cNTS NA and GLP-1 neurons, inhibit food intake, and 
activate the HPA axis also inhibit gastric emptying, likely via direct or indirect NA-, PrRP-, and 
GLP-1-mediated effects on autonomic outflow (Callahan and Rinaman, 1998; Hellstrom and 
Naslund, 2001; Rinaman, 2003; Rogers et al., 2003; Grabauskas et al., 2004; Rinaman, 2004; 
Nakade et al., 2006a; Balcita-Pedicino and Rinaman, 2007; Seto et al., 2008; Hayes et al., 2009).  
States of threatened homeostasis are met by a complex but generally predictable 
repertoire of physiological and behavioral stress responses (Chrousos, 1998; Kyrou and Tsigos, 
2009), including suppression of food intake (Dess and Vanderweele, 1994; Calvez et al., 2011).  
Stress responses are adaptive in the short term, because they shift the allocation of behavioral 
and physiological resources away from procuring and storing energy, and towards mobilizing 
energy and altering behavior to cope with the homeostatic threat.  Experimental stressors are 
diverse in nature and magnitude, but can be categorized as either visceral (a.k.a. 
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interoceptive/physiological), or cognitive (a.k.a. neurogenic/psychological). Visceral stressors 
typically comprise unconditioned stimuli that present a direct challenge to physiological 
homeostasis, such as dehydration, toxemia, infection, or gastrointestinal stimulation.  Their 
ability to activate the HPA axis largely depends on direct and relayed projections from spinal and 
hindbrain viscerosensory neurons to CRH neurons within the mpPVN, including projections 
from PrRP and GLP-1 neurons (Figure 19).  Cognitive stressors originate from conditioned and 
unconditioned cues that are processed through the cortex and hippocampus before engaging the 
limbic forebrain and hypothalamus (Figure 19).  Cognitive stressors in rats and mice include 
predator cues, open illuminated spaces, restraint/immobilization, and conditioned stimuli 
previously associated with an interoceptive or cognitive stressor.  Thus, cognitive stressors 
predict an impending challenge to homeostasis, including the challenge of a large meal, which 
can be a visceral stressor.  At least some cognitive stressors (i.e., mild footshock and restraint) do 
not require hindbrain inputs to the mpPVN in order to activate the HPA axis. However, GLP-1, 
PrRP, and NA neurons are activated by these and other cognitive stressors (Li et al., 1996; 
Morales and Sawchenko, 2003; Zhu and Onaka, 2003; Maniscalco et al., 2012a), likely due to 
recruitment of descending inputs to the cNTS that arise from stress-sensitive regions of the 
hypothalamus and limbic forebrain (Dayas et al., 2001; Buller et al., 2003a; Dayas et al., 2004; 
Blevins and Baskin, 2010) (Figure 19).  Our working hypothesis is that, similar to satiation, 
stress-induced hypophagia depends on the recruitment of PrRP and GLP-1 neurons that 
participate in stressor-induced decreases in meal size (Morley et al., 1985).  We propose that 
PrRP and GLP-1 neurons participate in satiation and stress-induced hypophagia regardless of 
whether these neurons are recruited directly via interoceptive/viscerosensory inputs to the cNTS, 
or indirectly via descending projections from the hypothalamus and limbic forebrain (Figure 19).  
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However, the potential role of PrRP or GLP-1 neurons in mediating stress-induced hypophagia 
has thus far been examined in only a small number of experimental models.  The following 
paragraphs highlight these relatively limited findings, which cumulatively support the view that 
the ability of stressors to recruit PrRP and/or GLP-1 neurons contributes importantly to their 
ability to suppress food intake. 
 
Cholecystokinin octapeptide:  CCK was the first peptide hormone proposed to act as a 
physiological within-meal satiety signal (Gibbs et al., 1973).  Endogenous CCK is released from 
the upper intestine by nutrient stimulation during and after a meal, binding to peripheral CCK 
receptors to thereby increase the activity of glutamatergic vagal sensory inputs to the cNTS 
(Bednar et al., 1994).  Without challenging the role of endogenous CCK as a satiety factor, 
synthetic CCK also has been used as a pharmacological tool to activate central neural circuits 
that respond to gastric vagal stimulation.  Such studies have demonstrated that systemic CCK 
dose-dependently decreases meal size (West et al., 1984) and elicits cFos activation of cNTS 
neurons (Zittel et al., 1999), including NA neurons (Maniscalco et al., 2012a) that presumably 
co-express PrRP .  Moderate to high doses of CCK (i.e., 10-100 g/kg BW) activate GLP-1 and 
NA neurons, including PrRP neurons (Luckman, 1992; Rinaman et al., 1993; Rinaman et al., 
1995; Verbalis et al., 1995; Lawrence et al., 2002; Bechtold and Luckman, 2006; Babic et al., 
2009) that project to the PVN (Rinaman et al., 1995) and activate CRH and oxytocin neurons 
(Verbalis et al., 1991).  Systemic CCK at doses of ~1-3 g/kg BW, which many researchers 
would argue are within the physiological range, are “stressful” in that they elevate plasma levels 
of adrenocorticotropic hormone (ACTH) in rats (Kamilaris et al., 1992); higher CCK doses 
produce larger HPA axis responses.  CCK delivered at a lower dose (i.e., 0.5 g/kg BW) does 
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not activate the HPA axis (Kamilaris et al., 1992). Although hypophagic effects of lower doses 
of CCK (i.e., ≤ 0.5μg/kg BW) have been reported using various systemic routes of 
administration and dietary conditions, to our knowledge there are no reports of parallel HPA axis 
activation under these conditions.  As the hypothalamus and the entire forebrain are unnecessary 
for the ability of CCK to inhibit intake (Grill and Smith, 1988), it follows that HPA axis 
activation also is unnecessary for CCK-induced hypophagia.  However, in the absence of 
evidence indicating otherwise, exogenous CCK-induced hypophagia appears to be accompanied 
by HPA axis activation, presumably because exogenous CCK activates hindbrain neurons that 
inhibit food intake and neurons that activate hypothalamic CRH neurons. 
A2 neurons, including PrRP neurons, are necessary for the ability of a moderate to high 
dose of CCK to reduce meal size, and also are necessary for CCK-induced activation of neurons 
within the PVN (Rinaman, 2003).  Interestingly, DbH -/- mice (which cannot convert dopamine 
to NA) show no deficiencies in the ability of CCK to reduce food intake (Cannon and Palmiter, 
2003), suggesting that PrRP rather than NE is the principal mediator of CCK-induced 
hypophagia, at least in mice.  Indeed, a later study confirmed that PrRP signaling is necessary for 
the ability of exogenous CCK to suppress food intake in mice (Bechtold and Luckman, 2006).  
CCK activates cFos expression by GLP-1 neurons (Maniscalco & Rinaman, 2012; Rinaman, 
1999), but GLP-1 neuronal recruitment appears to be insufficient to support CCK hypophagia in 
rats with A2 neuronal loss, which would include loss of cNTS PrRP neurons (Rinaman, 2003). 
However, there are no published reports indicating whether GLP-1R signaling is necessary for 
CCK-induced hypophagia in either rats or mice.  
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Lithium Chloride (LiCl):  Peripheral administration of the nauseogenic agent LiCl, an 
experimental model of toxemia, potently increases plasma corticosterone and inhibits food intake 
in rats (McCann et al., 1989).  Unlike satiation, LiCl reduces food intake in rats by reducing 
feeding frequency, without reducing meal size (West et al., 1987).  While LiCl treatment 
activates cFos within A2 and GLP-1 neurons in rats and mice (Rinaman, 1999a, b; Lachey et al., 
2005; Rinaman and Dzmura, 2007), one report indicates that a hypophagic dose of LiCl in rats 
does not activate the PrRP-positive subpopulation of A2 neurons (Lawrence et al., 2002).   This 
result suggests that LiCl suppresses food intake through non-PrRP signaling pathways, and that 
only stimuli related to normal satiation are sufficient to recruit PrRP neurons, as hypothesized 
previously (Luckman and Lawrence, 2003). Pharmacological blockade of central GLP-1 
receptors or selective lesions that destroy A2 neurons, likely including PrRP neurons, attenuates 
(but does not abolish) the ability of LiCl to inhibit food intake in rats (Rinaman, 1999b; Seeley et 
al., 2000; Kinzig et al., 2002; Rinaman and Dzmura, 2007), and central GLP-1R antagonism 
blunts LiCl-induced activation of the HPA axis (Kinzig et al., 2003).  Central GLP-1R 
antagonism also decreases LiCl-induced cFos in the rat cNTS (Thiele et al., 1998), evidence that 
GLP-1R signaling contributes to LiCl-induced recruitment of cNTS neurons. Conversely, 
although LiCl activates GLP-1 neurons in mice, neither GLP-1R antagonism in wild type mice 
nor the absence of GLP-1R signaling in GLP-1R -/- mice attenuates the hypophagic effects of 
LiCl (Lachey et al., 2005).  These disparate findings in rats and mice suggest important species 
differences in the role of GLP-1 signaling in responses to toxemia and other nauseogenic 
treatments.   
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 Immune challenge: Experimental models of infection, including systemic 
lipopolysaccharide (LPS; the major outer membrane component of gram-negative bacteria), 
promote the release of pro-inflammatory cytokines, elevate plasma levels of ACTH and 
corticosterone (Sapolsky et al., 1987; Hansen et al., 2000; Serrats and Sawchenko, 2006), and 
dose-dependently suppress food intake (Uehara et al., 1989; Kaneta and Kusnecov, 2005). 
Bacterial infections, LPS administration, and cytokines drive central stress responses via 
receptors located on vagal afferent terminals (Watkins et al., 1995; Fleshner et al., 1998; Goehler 
et al., 1999; Hosoi et al., 2005) and/or on endothelial and perivascular cells (Sawchenko et al., 
2000; Zhang et al., 2003), and signaling through both routes engages cNTS neurons.  LPS 
administered into the brain ventricles in rats reduces food intake primarily by reducing meal size 
(Plata-Salaman and Borkoski, 1993).  Conversely, systemic administration of LPS reduces intake 
by reducing meal frequency (Langhans et al., 1990; Langhans et al., 1993), suggesting that 
central and peripheral routes of administration engage different feeding control circuits.  
Systemic LPS increases hindbrain PrRP gene expression (Mera et al., 2006), and activates A2 
neurons, GLP-1 neurons, and PVN neurons to express cFos (Rinaman, 1999a).  PVN and HPA 
axis activation in response to immune challenge is significantly attenuated in rats after unilateral 
transection of ascending projections from the cNTS to the PVN that interrupt both PrRP and 
GLP-1 signaling pathways (Li et al., 1996), or by selective neurochemical lesions of NA neurons 
(likely including PrRP neurons) that innervate the PVN (Bienkowski and Rinaman, 2008).  Grill 
and colleagues (Grill et al., 2004) demonstrated that LPS-induced hypophagia is dependent on 
hindbrain, but not forebrain, GLP-1R signaling.  However, hypophagic (and HPA axis) 
responses to LPS are intact in GPR10 -/- mice (Bechtold and Luckman, 2006), evidence that 
PrRP signaling is unnecessary for stress-induced hypophagia in this species. Taken together, 
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these studies suggest that the hypophagic and HPA axis responses to bacterial infection and 
proinflammatory cytokines depend in large part on the recruitment of NA and GLP-1 neurons, 
while the role of PrRP signaling has been challenged in mice, and not yet explored in rats.  
 
 Immobilization/restraint:  One of the most commonly used models of cognitive stress is 
physical restraint, which activates the HPA axis and suppresses food intake (Rybkin et al., 1997; 
Kinzig et al., 2008; Seto et al., 2008; Calvez et al., 2011).  A recent study investigated whether 
restraint and forced swim stress inhibited food intake in rats by reducing meal size, meal number, 
or both.  Similar to satiation, restraint and forced swim stress both reduced food intake by 
reducing meal size and duration (Calvez et al., 2011), supporting the view that these stressors 
engage circuits that also are engaged by satiety signals.  Restraint increases PrRP gene 
expression (Mera et al., 2006) and also activates cFos in NA neurons, including PrRP neurons 
(Dayas et al., 2001; Maruyama et al., 2001; Banihashemi et al., 2011), apparently via descending 
projections from the PVN (Dayas et al., 2001; Dayas et al., 2004).  Recent findings in our 
laboratory indicate that restraint also activates GLP-1 neurons in rats (Maniscalco et al., 2012a).  
The ability of restraint to inhibit food intake is closely linked to its ability to inhibit vagally-
mediated gastric emptying (Seto et al., 2008; Suzuki and Hibi, 2010).  However, it currently is 
unknown whether the ability of restraint or any other cognitive stressor to decrease gastric 
emptying and food intake depends on central PrRP or GLP-1 receptor signaling. 
 
CONCLUSION 
Stress affects both food intake and energy balance, and food intake can itself be stressful 
(Woods, 1991).  For the purpose of this review, we set out to gather and interpret experimental 
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evidence that satiety signals and stress engage a common set of neurons that contribute to the 
inhibition of food intake. Hindbrain PrRP and GLP-1 neurons satisfy many of the criteria that 
one might consider important for such a common set of neurons.  Both neuronal populations are 
recruited to express cFos in animals exposed to satiety signals and many hypophagic stressors, 
and PrRP and GLP-1 signaling pathways impact body energy balance by reducing food intake 
and activating the HPA axis.  Based on our review of the available literature, we propose that 
hindbrain PrRP and GLP-1 neurons represent important points of central integration in the 
control of energy intake and metabolism during feeding and in response to other acute 
homeostatic challenges.  We do not argue that PrRP and GLP-1 neurons are the only important 
players in these coordinated processes.  Instead, we present this evidence to establish a working 
hypothesis about the unique role played by these cNTS neurons within the anatomically broad 
and complex neural systems that regulate energy homeostasis on a day-to-day basis.  
Experimental predictions arising from this hypothesis will be challenged by ongoing and future 
work in our laboratory.    
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